Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	minus-end-directed microtubule motor activity	DNAH3 DNAH14 DNAH1 DNAH17 DNAH8	5.30e-07	18	187	5	GO:0008569
GeneOntologyMolecularFunction	dynein intermediate chain binding	DNAH3 DNAH14 DNAH1 DNAH17 DYNLT5 DNAH8	1.14e-06	37	187	6	GO:0045505
GeneOntologyMolecularFunction	dynein light intermediate chain binding	DNAH3 DNAH14 DNAH1 DNAH17 DNAH8	5.63e-06	28	187	5	GO:0051959
GeneOntologyMolecularFunction	carboxylic acid binding	ACACB UGT1A10 UGT1A8 L1CAM UGT1A9 PPARG CPS1 GRM7 ST8SIA3 TYMS	8.89e-05	239	187	10	GO:0031406
GeneOntologyMolecularFunction	cytoskeletal motor activity	DNAH3 MYO9B DNAH14 DNAH1 DNAH17 MYO15A DNAH8	1.24e-04	118	187	7	GO:0003774
GeneOntologyMolecularFunction	organic acid binding	ACACB UGT1A10 UGT1A8 L1CAM UGT1A9 PPARG CPS1 GRM7 ST8SIA3 TYMS	1.46e-04	254	187	10	GO:0043177
GeneOntologyMolecularFunction	5-methylcytosine dioxygenase activity	TET2 TET1	2.60e-04	3	187	2	GO:0070579
GeneOntologyMolecularFunction	kinase binding	TPCN2 UGT1A10 UGT1A8 PARP8 GATA6 UGT1A9 DGKQ ACE LYST RCC2 PTK2 GAB2 EEF1A1 CRY1 NEDD9 FCRL3 WDCP STAU2 IRAK4 PRKCB EP300	3.05e-04	969	187	21	GO:0019900
GeneOntologyMolecularFunction	microtubule motor activity	DNAH3 DNAH14 DNAH1 DNAH17 DNAH8	5.05e-04	70	187	5	GO:0003777
GeneOntologyMolecularFunction	actin binding	ESPN MAP1B MYO9B ACE PTK2 LMOD3 PDLIM1 PLEKHG3 SVIL SYNE2 TLN2 MYO15A MRTFA	6.04e-04	479	187	13	GO:0003779
GeneOntologyBiologicalProcess	flavonoid metabolic process	UGT1A10 UGT1A8 UGT1A9 SULT1B1	4.39e-06	13	187	4	GO:0009812
GeneOntologyBiologicalProcess	estrogen catabolic process	UGT1A10 UGT1A8 UGT1A9	7.24e-06	5	187	3	GO:0006711
GeneOntologyBiologicalProcess	phenylpropanoid catabolic process	UGT1A10 UGT1A8 UGT1A9	1.44e-05	6	187	3	GO:0046271
GeneOntologyBiologicalProcess	coumarin catabolic process	UGT1A10 UGT1A8 UGT1A9	1.44e-05	6	187	3	GO:0046226
GeneOntologyBiologicalProcess	flavone metabolic process	UGT1A10 UGT1A8 UGT1A9	1.44e-05	6	187	3	GO:0051552
GeneOntologyBiologicalProcess	plasma membrane bounded cell projection morphogenesis	SEMA4F NYAP2 MAP1B MYO9B L1CAM ADGRB1 ADGRB3 DOCK10 LAMA5 MGLL SIN3A PTK2 ATL1 LIFR SLITRK2 TET1 ITSN2 STAU2 ROBO1 PARD3 EP300	1.81e-05	819	187	21	GO:0120039
GeneOntologyBiologicalProcess	cell projection morphogenesis	SEMA4F NYAP2 MAP1B MYO9B L1CAM ADGRB1 ADGRB3 DOCK10 LAMA5 MGLL SIN3A PTK2 ATL1 LIFR SLITRK2 TET1 ITSN2 STAU2 ROBO1 PARD3 EP300	2.05e-05	826	187	21	GO:0048858
GeneOntologyBiologicalProcess	regulation of cellular component biogenesis	ESPN INTU MAP1B L1CAM ADGRB1 ADGRB3 DOCK10 BIRC2 PLEKHG2 PPARG ACE RCC2 PTK2 LMOD3 SLITRK2 RHPN2 ARHGEF10 KLF5 G3BP2 RAB3GAP2 SVIL SYNE2 STAU2 ROBO1 CNOT2 EP300	2.80e-05	1189	187	26	GO:0044087
GeneOntologyBiologicalProcess	hormone catabolic process	UGT1A10 UGT1A8 UGT1A9 ACE	3.47e-05	21	187	4	GO:0042447
GeneOntologyBiologicalProcess	type II pneumocyte differentiation	FNDC3B GATA6 IGF1	3.97e-05	8	187	3	GO:0060510
GeneOntologyBiologicalProcess	neuron projection morphogenesis	SEMA4F NYAP2 MAP1B L1CAM ADGRB1 ADGRB3 DOCK10 LAMA5 MGLL SIN3A PTK2 ATL1 LIFR SLITRK2 TET1 ITSN2 STAU2 ROBO1 PARD3 EP300	4.28e-05	802	187	20	GO:0048812
GeneOntologyBiologicalProcess	neuron development	SEMA4F FAT4 NYAP2 MAP1B L1CAM ADGRB1 ADGRB3 DOCK10 LAMA5 MGLL SIN3A GRM7 NCDN PTK2 ATL1 SCYL2 LIFR FRY SLITRK2 TENM4 TET1 ITSN2 STAU2 UGCG ROBO1 PARD3 EP300 MRTFA CREB3L2	5.56e-05	1463	187	29	GO:0048666
GeneOntologyBiologicalProcess	phenylpropanoid metabolic process	UGT1A10 UGT1A8 UGT1A9	8.40e-05	10	187	3	GO:0009698
GeneOntologyBiologicalProcess	coumarin metabolic process	UGT1A10 UGT1A8 UGT1A9	8.40e-05	10	187	3	GO:0009804
GeneOntologyBiologicalProcess	regulation of synapse assembly	MAP1B L1CAM ADGRB1 ADGRB3 DOCK10 PTK2 SLITRK2 STAU2 ROBO1	9.80e-05	202	187	9	GO:0051963
GeneOntologyBiologicalProcess	neuron projection development	SEMA4F FAT4 NYAP2 MAP1B L1CAM ADGRB1 ADGRB3 DOCK10 LAMA5 MGLL SIN3A GRM7 NCDN PTK2 ATL1 LIFR FRY SLITRK2 TET1 ITSN2 STAU2 ROBO1 PARD3 EP300 MRTFA CREB3L2	1.01e-04	1285	187	26	GO:0031175
GeneOntologyBiologicalProcess	positive regulation of nervous system development	MAP1B L1CAM ADGRB1 ADGRB3 PPARG ACE PTK2 SLITRK2 IGF1 TENM4 STAU2 ROBO1 EP300	1.20e-04	418	187	13	GO:0051962
GeneOntologyBiologicalProcess	regulation of cell junction assembly	MAP1B L1CAM ADGRB1 ADGRB3 DOCK10 ACE RCC2 PTK2 SLITRK2 STAU2 ROBO1	1.26e-04	309	187	11	GO:1901888
GeneOntologyBiologicalProcess	positive regulation of heart growth	AKAP6 ACACB GATA6 IGF1 EP300	2.12e-04	60	187	5	GO:0060421
GeneOntologyBiologicalProcess	regulation of angiotensin metabolic process	ACE EP300	2.44e-04	3	187	2	GO:0060177
GeneOntologyBiologicalProcess	regulation of cardiac muscle hypertrophy	AKAP6 ACACB PPARG PTK2 IGF1 EP300	2.56e-04	97	187	6	GO:0010611
GeneOntologyBiologicalProcess	tricarboxylic acid cycle	PDHB DHTKD1 NNT SDHB	2.75e-04	35	187	4	GO:0006099
GeneOntologyBiologicalProcess	regulation of muscle hypertrophy	AKAP6 ACACB PPARG PTK2 IGF1 EP300	3.02e-04	100	187	6	GO:0014743
GeneOntologyBiologicalProcess	lung secretory cell differentiation	FNDC3B GATA6 IGF1	3.08e-04	15	187	3	GO:0061140
GeneOntologyBiologicalProcess	cardiac muscle hypertrophy	AKAP6 ACACB GATA6 PPARG PTK2 IGF1 EP300	3.20e-04	142	187	7	GO:0003300
GeneOntologyCellularComponent	dynein complex	DNAH3 DNAH14 DNAH1 DNAH17 DYNLT5 DCTN4 DNAH8	5.09e-07	54	187	7	GO:0030286
GeneOntologyCellularComponent	axonemal dynein complex	DNAH3 DNAH1 DNAH17 DNAH8	6.77e-05	25	187	4	GO:0005858
GeneOntologyCellularComponent	microtubule associated complex	DNAH3 MAP1B DNAH14 DNAH1 DNAH17 DYNLT5 DCTN4 DNAH8	1.03e-04	161	187	8	GO:0005875
Domain	Dynein_heavy_chain_D4_dom	DNAH3 DNAH14 DNAH1 DNAH8	8.82e-06	14	186	4	IPR024317
Domain	Dynein_HC_stalk	DNAH3 DNAH14 DNAH1 DNAH8	8.82e-06	14	186	4	IPR024743
Domain	MT	DNAH3 DNAH14 DNAH1 DNAH8	8.82e-06	14	186	4	PF12777
Domain	AAA_8	DNAH3 DNAH14 DNAH1 DNAH8	8.82e-06	14	186	4	PF12780
Domain	DHC_fam	DNAH3 DNAH14 DNAH1 DNAH8	1.19e-05	15	186	4	IPR026983
Domain	Dynein_heavy	DNAH3 DNAH14 DNAH1 DNAH8	1.19e-05	15	186	4	PF03028
Domain	Dynein_heavy_dom	DNAH3 DNAH14 DNAH1 DNAH8	1.19e-05	15	186	4	IPR004273
Domain	Tet_JBP	TET2 TET1	9.86e-05	2	186	2	PF12851
Domain	2OGFeDO_noxygenase_dom	TET2 TET1	9.86e-05	2	186	2	IPR024779
Domain	Tet_JBP	TET2 TET1	9.86e-05	2	186	2	SM01333
Domain	GPCR_2_brain_angio_inhib	ADGRB1 ADGRB3	2.94e-04	3	186	2	IPR008077
Domain	Dynein_heavy_dom-2	DNAH3 DNAH1 DNAH8	3.26e-04	14	186	3	IPR013602
Domain	DHC_N2	DNAH3 DNAH1 DNAH8	3.26e-04	14	186	3	PF08393
Domain	ATPase_dyneun-rel_AAA	DNAH3 DNAH1 DNAH8	3.26e-04	14	186	3	IPR011704
Domain	AAA_5	DNAH3 DNAH1 DNAH8	3.26e-04	14	186	3	PF07728
Pathway	KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SOD1_TO_RETROGRADE_AXONAL_TRANSPORT	DNAH3 DNAH1 DNAH17 DCTN4 DNAH8	8.53e-06	27	150	5	M47755
Pubmed	Human transcription factor protein interaction networks.	TET2 NCOA6 IRS4 ACACB DHX37 GATA6 ZMYM2 BEND3 SMG5 SIN3A PPARG EYA3 ZHX2 RFX1 RCC2 IKZF5 FAT1 KLF5 WDCP ZMIZ2 G3BP2 SVIL SYNE2 STAU2 OTUD4 CNOT2 EP300 PYGO1	5.62e-09	1429	191	28	35140242
Pubmed	Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics.	A2M ISYNA1 ADGRB3 SMG5 FCHO2 RCC2 PTK2 FRY TENM4 STAU2 DZIP3 OTUD4 TLN2 TNKS DDX20 PARD3	1.01e-08	475	191	16	31040226
Pubmed	Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones.	AKAP6 NCOA6 ADGRB3 DOCK10 SMG5 TENM4 ARHGEF10 RAB3GAP2 SYNE2 TLN2 MRTFA	5.41e-08	225	191	11	12168954
Pubmed	Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.	A2M FNDC3B FRAS1 MAP1B DHX37 DOCK10 ATL3 SIN3A ANKZF1 RCC2 NCDN PTK2 RHPN2 OSBPL3 WDCP BUB1 DNA2	1.34e-07	650	191	17	38777146
Pubmed	Cooperative Regulation of Intestinal UDP-Glucuronosyltransferases 1A8, -1A9, and 1A10 by CDX2 and HNF4α Is Mediated by a Novel Composite Regulatory Element.	UGT1A10 UGT1A8 UGT1A9	1.63e-07	3	191	3	29519853
Pubmed	Cloning and characterization of the human UDP-glucuronosyltransferase 1A8, 1A9, and 1A10 gene promoters: differential regulation through an interior-like region.	UGT1A10 UGT1A8 UGT1A9	1.63e-07	3	191	3	12847094
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	AKAP6 TET2 ZBTB38 VWF PDHB ADGRB3 ZMYM2 BIRC2 CHD9 SMG5 REV3L EYA3 PTK2 EEF1A1 SCYL2 FRY ARHGEF10 ROBO1 TLN2 TNKS WDR17 ACBD3 CNOT2 EP300	1.85e-07	1285	191	24	35914814
Pubmed	Genetic determinants influencing human serum metabolome among African Americans.	UGT1A10 UGT1A8 UGT1A9 CPS1 ACE	1.85e-07	24	191	5	24625756
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	NYAP2 ERH ADGRB3 ZMYM2 NCDN PTK2 EEF1A1 WDR91 FRY OSBPL3 G3BP2 SVIL SYNE2 DZIP3 OTUD4 PRKCB TLN2 TNKS PARD3 UNC79	4.10e-07	963	191	20	28671696
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	TET2 IRS4 ACACB ZMYM2 BEND3 RFX1 PHC1 WDCP ZMIZ2 RAB3GAP2 TET1 BUB1 MRTFA	6.26e-07	418	191	13	34709266
Pubmed	TET-Mediated Hypermethylation Primes SDH-Deficient Cells for HIF2α-Driven Mesenchymal Transition.	TET2 TET1 SDHB	6.50e-07	4	191	3	32234487
Pubmed	Human metabolic individuality in biomedical and pharmaceutical research.	UGT1A10 UGT1A8 UGT1A9 REV3L CPS1 ACE	7.29e-07	57	191	6	21886157
Pubmed	Identification of dynein heavy chain genes expressed in human and mouse testis: chromosomal localization of an axonemal dynein gene.	DNAH3 DNAH1 DNAH17 DNAH8	8.45e-07	14	191	4	9373155
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	TET2 NCOA6 IRS4 MAP1B PARP8 PLEKHG2 LYST GAB2 EEF1A1 ARHGEF10 PLEKHG3 OSBPL3 RAB3GAP2 SVIL SYNE2 TET1 NUB1 PARD3	1.46e-06	861	191	18	36931259
Pubmed	Tet1 and Tet2 maintain mesenchymal stem cell homeostasis via demethylation of the P2rX7 promoter.	TET2 LYST TET1	1.62e-06	5	191	3	29858571
Pubmed	Variation of hepatic glucuronidation: Novel functional polymorphisms of the UDP-glucuronosyltransferase UGT1A4.	UGT1A10 UGT1A8 UGT1A9	1.62e-06	5	191	3	15057901
Pubmed	Phase II metabolism of hesperetin by individual UDP-glucuronosyltransferases and sulfotransferases and rat and human tissue samples.	UGT1A10 UGT1A8 UGT1A9 SULT1B1	2.54e-06	18	191	4	20056724
Pubmed	TNF-α inhibits glucocorticoid receptor-induced gene expression by reshaping the GR nuclear cofactor profile.	FNBP1 TRAPPC11 NCOA6 FAT4 NYAP2 ACACB ZMYM2 REV3L RFX1 G3BP2 SYNE2 ITSN2 OTUD4 WDR17 EP300	2.79e-06	638	191	15	31182584
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	FNBP1 INTU FRAS1 DOCK10 BEND3 ZHX2 NCDN TENM4 RAB3GAP2 ITSN2 DZIP3 OTUD4	2.96e-06	407	191	12	12693553
Pubmed	A genome-wide assessment of variability in human serum metabolism.	UGT1A10 UGT1A8 UGT1A9 ACE	3.20e-06	19	191	4	23281178
Pubmed	Circadian Clock Component Rev-erbα Regulates Diurnal Rhythm of UDP-Glucuronosyltransferase 1a9 and Drug Glucuronidation in Mice.	UGT1A10 UGT1A8 UGT1A9	3.22e-06	6	191	3	32527940
Pubmed	Use of glucuronidation fingerprinting to describe and predict mono- and dihydroxyflavone metabolism by recombinant UGT isoforms and human intestinal and liver microsomes.	UGT1A10 UGT1A8 UGT1A9	3.22e-06	6	191	3	20297805
Pubmed	Transcription factor protein interactomes reveal genetic determinants in heart disease.	IRS4 DHX37 GATA6 ZMYM2 BEND3 SIN3A CPS1 PHC1 EEF1A1P5 WDR91 INTS14 EP300	3.27e-06	411	191	12	35182466
Pubmed	Assignment of the human UDP glucuronosyltransferase gene (UGT1A1) to chromosome region 2q37.	UGT1A10 UGT1A8 UGT1A9	5.61e-06	7	191	3	8467709
Pubmed	Cyp3a11-mediated testosterone-6β-hydroxylation decreased, while UGT1a9-mediated propofol O-glucuronidation increased, in mice with diabetes mellitus.	UGT1A10 UGT1A8 UGT1A9	5.61e-06	7	191	3	27514509
Pubmed	Isolation of several human axonemal dynein heavy chain genes: genomic structure of the catalytic site, phylogenetic analysis and chromosomal assignment.	DNAH3 DNAH1 DNAH8	5.61e-06	7	191	3	9256245
Pubmed	Molecular cloning of two cDNAs encoding the mouse bilirubin/phenol family of UDP-glucuronosyltransferases (mUGTBr/p).	UGT1A10 UGT1A8 UGT1A9	5.61e-06	7	191	3	8464825
Pubmed	Alternatively spliced products of the UGT1A gene interact with the enzymatically active proteins to inhibit glucuronosyltransferase activity in vitro.	UGT1A10 UGT1A8 UGT1A9	8.95e-06	8	191	3	20610558
Pubmed	Disposition of flavonoids via enteric recycling: enzyme stability affects characterization of prunetin glucuronidation across species, organs, and UGT isoforms.	UGT1A10 UGT1A8 UGT1A9	8.95e-06	8	191	3	18052087
Pubmed	Oligomerization of the UDP-glucuronosyltransferase 1A proteins: homo- and heterodimerization analysis by fluorescence resonance energy transfer and co-immunoprecipitation.	UGT1A10 UGT1A8 UGT1A9	8.95e-06	8	191	3	17179145
Pubmed	Robust phosphoproteomic profiling of tyrosine phosphorylation sites from human T cells using immobilized metal affinity chromatography and tandem mass spectrometry.	FNBP1 LCP2 NEDD9 PDLIM1 ITSN2 OTUD4 PARD3	9.37e-06	133	191	7	15144186
Pubmed	Characterization of an exchangeable gene trap using pU-17 carrying a stop codon-beta geo cassette.	TET2 TRIT1 L1CAM TENM4 OSBPL3 WDCP G3BP2 SVIL TET1 UGCG TLN2 PARD3 CNOT2	9.44e-06	536	191	13	15840001
Pubmed	Exchangeable gene trap using the Cre/mutated lox system.	TET2 TRIT1 L1CAM TENM4 OSBPL3 WDCP G3BP2 SVIL TET1 UGCG TLN2 PARD3 CNOT2	9.82e-06	538	191	13	10512203
Pubmed	A genome-wide association study identifies UGT1A1 as a regulator of serum cell-free DNA in young adults: The Cardiovascular Risk in Young Finns Study.	UGT1A10 UGT1A8 UGT1A9	1.34e-05	9	191	3	22511988
Pubmed	Family-based genome-wide association scan of attention-deficit/hyperactivity disorder.	UGT1A10 UGT1A8 UGT1A9	1.34e-05	9	191	3	20732626
Pubmed	Elongation factor 1 alpha1 and genes associated with Usher syndromes are downstream targets of GBX2.	EEF1A1 ROBO1 MYO15A	1.34e-05	9	191	3	23144817
Pubmed	A multi-factor trafficking site on the spliceosome remodeling enzyme BRR2 recruits C9ORF78 to regulate alternative splicing.	IRS4 PDHB CWC27 ZMYM2 SIN3A RFX1 NCDN INTS14 RAB3GAP2 STAU2 INTS4 NNT TOR1AIP1	1.50e-05	560	191	13	35241646
Pubmed	E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins.	SEMA4F DNAH3 FAT4 ERH ADGRB1 UGT1A9 REV3L DNAH14 EEF1A1 FRY PDLIM1 GALNT11 UGCG PRKCB RBM41	1.53e-05	736	191	15	29676528
Pubmed	Toward a catalog of human genes and proteins: sequencing and analysis of 500 novel complete protein coding human cDNAs.	ESPN SEMA4F TRAPPC11 PDHB PARP8 ZMYM2 FCHO2 MYCBPAP WDR91 LMOD3 INTS14 ZMIZ2 SYNE2 TMEM131L NNT	1.90e-05	750	191	15	11230166
Pubmed	TET1 and hydroxymethylcytosine in transcription and DNA methylation fidelity.	TET2 SIN3A TET1	1.90e-05	10	191	3	21490601
Pubmed	Association of SNPs in the UGT1A gene cluster with total bilirubin and mortality in the Diabetes Heart Study.	UGT1A10 UGT1A8 UGT1A9	1.90e-05	10	191	3	23642732
Pubmed	Disruption of FAT10-MAD2 binding inhibits tumor progression.	FAT1 BUB1 NUB1	1.90e-05	10	191	3	25422469
Pubmed	UDP-glucuronosyltransferases.	UGT1A10 UGT1A8 UGT1A9	1.90e-05	10	191	3	11465080
Pubmed	Sex differences in environmental and genetic factors for hypertension.	VWF PPARG ACE	1.90e-05	10	191	3	18724972
Pubmed	A genome-wide association study for serum bilirubin levels and gene-environment interaction in a Chinese population.	UGT1A10 UGT1A8 UGT1A9	1.90e-05	10	191	3	23371916
Pubmed	A genome-wide association study of total bilirubin and cholelithiasis risk in sickle cell anemia.	UGT1A10 UGT1A8 UGT1A9	1.90e-05	10	191	3	22558097
Pubmed	A human skeletal muscle interactome centered on proteins involved in muscular dystrophies: LGMD interactome.	AKAP6 FNDC3B ZBTB38 VWF OSGEP DYSF EEF1A1 NEDD9 SYNE2 INTS4 TNKS PARD3	2.19e-05	497	191	12	23414517
Pubmed	Elf5-centered transcription factor hub controls trophoblast stem cell self-renewal and differentiation through stoichiometry-sensitive shifts in target gene networks.	MAP1B ZMYM2 SIN3A TFAP2C ORC1 INTS14	2.20e-05	102	191	6	26584622
Pubmed	Prediction of the coding sequences of unidentified human genes. XVI. The complete sequences of 150 new cDNA clones from brain which code for large proteins in vitro.	DNAH1 SCYL2 TENM4 SORCS2 TXNDC16 UNC79 MRTFA	2.33e-05	153	191	7	10718198
Pubmed	Identification of Zika Virus and Dengue Virus Dependency Factors using Functional Genomics.	PDHB L1CAM ATL3 CPS1 RCC2 SCYL2 PDLIM1 HPD NNT TOR1AIP1 SDHB	2.42e-05	422	191	11	27342126
Pubmed	Prediction of the coding sequences of unidentified human genes. IX. The complete sequences of 100 new cDNA clones from brain which can code for large proteins in vitro.	FNBP1 ADGRB3 LAMA5 NCDN GAB2 PLEKHG3	2.60e-05	105	191	6	9628581
Pubmed	Endocannabinoids modulate cortical development by configuring Slit2/Robo1 signalling.	L1CAM MGLL ROBO1	2.60e-05	11	191	3	25030704
Pubmed	SPATA2-Mediated Binding of CYLD to HOIP Enables CYLD Recruitment to Signaling Complexes.	TET2 ERH MAP1B BIRC2 RCC2 EEF1A1 SCYL2 G3BP2 SVIL OTUD4	2.83e-05	353	191	10	27545878
Pubmed	Proteome-scale mapping of binding sites in the unstructured regions of the human proteome.	NCOA6 IRS4 ACACB SIN3A PTK2 NEDD9 KLF5 ZMIZ2 BUB1 TNKS MRTFA	2.87e-05	430	191	11	35044719
Pubmed	pH Optimum of Hemagglutinin-Mediated Membrane Fusion Determines Sensitivity of Influenza A Viruses to the Interferon-Induced Antiviral State and IFITMs.	IFITM2 IFITM3	3.00e-05	2	191	2	28356532
Pubmed	Identification of focal adhesion kinase (FAK) and phosphatidylinositol 3-kinase (PI3-kinase) as Par3 partners by proteomic analysis.	PTK2 PARD3	3.00e-05	2	191	2	20191563
Pubmed	Distributive Processing by the Iron(II)/α-Ketoglutarate-Dependent Catalytic Domains of the TET Enzymes Is Consistent with Epigenetic Roles for Oxidized 5-Methylcytosine Bases.	TET2 TET1	3.00e-05	2	191	2	27362828
Pubmed	Stage-specific roles for tet1 and tet2 in DNA demethylation in primordial germ cells.	TET2 TET1	3.00e-05	2	191	2	23415914
Pubmed	Impaired muscle growth and response to insulin-like growth factor 1 in dysferlin-mediated muscular dystrophy.	DYSF IGF1	3.00e-05	2	191	2	21127009
Pubmed	Early Expression of Tet1 and Tet2 in Mouse Zygotes Altered DNA Methylation Status and Affected Embryonic Development.	TET2 TET1	3.00e-05	2	191	2	35955629
Pubmed	Distinct roles of the methylcytosine oxidases Tet1 and Tet2 in mouse embryonic stem cells.	TET2 TET1	3.00e-05	2	191	2	24474761
Pubmed	A hypothesis for insulin resistance in primary human adipocytes involving MRTF-A and suppression of PPARγ.	PPARG MRTFA	3.00e-05	2	191	2	32921413
Pubmed	PPARγ Pro12Ala and ACE ID polymorphisms are associated with BMI and fat distribution, but not metabolic syndrome.	PPARG ACE	3.00e-05	2	191	2	22168210
Pubmed	Oxysterol-binding protein-like 3 is a novel target gene of peroxisome proliferator-activated receptor γ in fatty liver disease.	PPARG OSBPL3	3.00e-05	2	191	2	36781118
Pubmed	CREB3L2-PPARgamma fusion mutation identifies a thyroid signaling pathway regulated by intramembrane proteolysis.	PPARG CREB3L2	3.00e-05	2	191	2	18757431
Pubmed	The protein MAP-1B links GABA(C) receptors to the cytoskeleton at retinal synapses.	GABRR1 MAP1B	3.00e-05	2	191	2	9892354
Pubmed	Redox-active quinones induces genome-wide DNA methylation changes by an iron-mediated and Tet-dependent mechanism.	TET2 TET1	3.00e-05	2	191	2	24214992
Pubmed	TET-mediated hydroxymethylcytosine at the Pparγ locus is required for initiation of adipogenic differentiation.	TET2 PPARG	3.00e-05	2	191	2	28100914
Pubmed	Ten-eleven translocation protein 1 modulates medulloblastoma progression.	TET2 TET1	3.00e-05	2	191	2	33926529
Pubmed	Coordination of engineered factors with TET1/2 promotes early-stage epigenetic modification during somatic cell reprogramming.	TET2 TET1	3.00e-05	2	191	2	24672749
Pubmed	The effects of Berberis vulgaris consumption on plasma levels of IGF-1, IGFBPs, PPAR-γ and the expression of angiogenic genes in women with benign breast disease: a randomized controlled clinical trial.	PPARG IGF1	3.00e-05	2	191	2	31752829
Pubmed	Influence of angiotensin-converting enzyme polymorphism gene, IGF-1, and other factors in the response rate of hematocrit to enalapril treatment in patients with posttransplant erythrocytosis.	ACE IGF1	3.00e-05	2	191	2	15848608
Pubmed	Tet1 and Tet2 Protect DNA Methylation Canyons against Hypermethylation.	TET2 TET1	3.00e-05	2	191	2	26598602
Pubmed	Identification of UDP-glucuronosyltransferases responsible for the glucuronidation of darexaban, an oral factor Xa inhibitor, in human liver and intestine.	UGT1A10 UGT1A9	3.00e-05	2	191	2	22031623
Pubmed	Staufen 2 regulates mGluR long-term depression and Map1b mRNA distribution in hippocampal neurons.	MAP1B STAU2	3.00e-05	2	191	2	21508097
Pubmed	Combined Loss of Tet1 and Tet2 Promotes B Cell, but Not Myeloid Malignancies, in Mice.	TET2 TET1	3.00e-05	2	191	2	26586431
Pubmed	Pharmacogenetic effect of the UGT polymorphisms on mycophenolate is modified by calcineurin inhibitors.	UGT1A8 UGT1A9	3.00e-05	2	191	2	18568343
Pubmed	Activation of pp125FAK by type 2B recombinant von Willebrand factor binding to platelet GPIb at a high shear rate occurs independently of alpha IIb beta 3 engagement.	VWF PTK2	3.00e-05	2	191	2	12543870
Pubmed	Flanking sequences influence the activity of TET1 and TET2 methylcytosine dioxygenases and affect genomic 5hmC patterns.	TET2 TET1	3.00e-05	2	191	2	35075236
Pubmed	Ten-Eleven Translocation 1 and 2 Confer Overlapping Transcriptional Programs for the Proliferation of Cultured Adult Neural Stem Cells.	TET2 TET1	3.00e-05	2	191	2	27778125
Pubmed	Characterization of two UDP glucuronosyltransferases that are predominantly expressed in human colon.	UGT1A10 UGT1A8	3.00e-05	2	191	2	9647757
Pubmed	Metabolic control of TH17 and induced Treg cell balance by an epigenetic mechanism.	TET2 TET1	3.00e-05	2	191	2	28783731
Pubmed	Novel Epigenetic Controlling of Hypoxia Pathway Related to Overexpression and Promoter Hypomethylation of TET1 and TET2 in RPE Cells.	TET2 TET1	3.00e-05	2	191	2	28252217
Pubmed	Sin3a-Tet1 interaction activates gene transcription and is required for embryonic stem cell pluripotency.	SIN3A TET1	3.00e-05	2	191	2	29733394
Pubmed	Transcriptional factors p300 and MRTF-A synergistically enhance the expression of migration-related genes in MCF-7 breast cancer cells.	EP300 MRTFA	3.00e-05	2	191	2	26476216
Pubmed	IGF1 and PPARG polymorphisms are associated with reduced estimated glomerular filtration rate in a cohort of children and adolescents with type 1 diabetes.	PPARG IGF1	3.00e-05	2	191	2	37338602
Pubmed	Myocardin-related transcription factor A (MRTF-A) activity-dependent cell adhesion is correlated to focal adhesion kinase (FAK) activity.	PTK2 MRTFA	3.00e-05	2	191	2	27708220
Pubmed	Decrease of 5-hydroxymethylcytosine and TET1 with nuclear exclusion of TET2 in small intestinal neuroendocrine tumors.	TET2 TET1	3.00e-05	2	191	2	30045709
Pubmed	Autoantibodies against TYMS and PDLIM1 proteins detected as circulatory signatures in Indian breast cancer patients.	TYMS PDLIM1	3.00e-05	2	191	2	27068564
Pubmed	Ten-Eleven Translocation Proteins Modulate the Response to Environmental Stress in Mice.	TET2 TET1	3.00e-05	2	191	2	30540950
Pubmed	Overexpression of Nedd9 is a prognostic marker of human gastric cancer.	PTK2 NEDD9	3.00e-05	2	191	2	24906654
Pubmed	Tet1 Deficiency Leads to Premature Reproductive Aging by Reducing Spermatogonia Stem Cells and Germ Cell Differentiation.	TET2 TET1	3.00e-05	2	191	2	32114381
Pubmed	Specific functions of TET1 and TET2 in regulating mesenchymal cell lineage determination.	TET2 TET1	3.00e-05	2	191	2	30606231
Pubmed	Ten-eleven translocation 2 modulates allergic inflammation by 5-hydroxymethylcytosine remodeling of immunologic pathways.	TET2 TET1	3.00e-05	2	191	2	34165552
Pubmed	Studies on the substrate specificity of human intestinal UDP- lucuronosyltransferases 1A8 and 1A10.	UGT1A10 UGT1A8	3.00e-05	2	191	2	10497143
Pubmed	Tet-mediated imprinting erasure in H19 locus following reprogramming of spermatogonial stem cells to induced pluripotent stem cells.	TET2 TET1	3.00e-05	2	191	2	26328763
Pubmed	Structural insight into substrate preference for TET-mediated oxidation.	TET2 TET1	3.00e-05	2	191	2	26524525
Pubmed	Sin3A recruits Tet1 to the PAH1 domain via a highly conserved Sin3-Interaction Domain.	SIN3A TET1	3.00e-05	2	191	2	30279502
Pubmed	Differences in the glucuronidation of bisphenols F and S between two homologous human UGT enzymes, 1A9 and 1A10.	UGT1A10 UGT1A9	3.00e-05	2	191	2	25547628
Pubmed	Influence of the PPAR-gamma2 Pro12Ala and ACE I/D polymorphisms on insulin sensitivity and training effects in healthy offspring of type 2 diabetic subjects.	PPARG ACE	3.00e-05	2	191	2	15778927
Interaction	HDAC4 interactions	ISYNA1 ADGRB3 SMG5 SIN3A REV3L PPARG FCHO2 CDPF1 RCC2 PTK2 GAB2 EEF1A1 FRY TENM4 STAU2 DZIP3 OTUD4 TLN2 TNKS DDX20 PARD3 SDHB	1.84e-06	744	188	22	int:HDAC4
GeneFamily	Dyneins, axonemal	DNAH3 DNAH14 DNAH1 DNAH17 DNAH8	9.50e-08	17	128	5	536
GeneFamily	Adhesion G protein-coupled receptors, subfamily B	ADGRB1 ADGRB3	1.49e-04	3	128	2	912
GeneFamily	Pleckstrin homology domain containing\|Rho guanine nucleotide exchange factors\|C2 domain containing	PLEKHG2 ARHGEF10 PLEKHG3 ITSN2	1.23e-03	66	128	4	722
GeneFamily	UDP glucuronosyltransferases	UGT1A10 UGT1A8 UGT1A9	1.48e-03	32	128	3	363
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HGABA	AKAP6 FNBP1 ZBTB38 MAP1B L1CAM ADGRB1 LAMA5 SLC6A15 SIN3A REV3L GRM7 ST8SIA3 LYST NCDN ATL1 LMOD3 FRY VWA5A CELF3 UGCG OTUD4 ROBO1 PRKCB TLN2 TNKS C2CD6 MGAT4C UNC79 FAM219A	2.02e-09	1106	190	29	M39071
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	MAP1B MYO9B ZMYM2 CHD9 MGLL REV3L ZHX2 PTK2 CRY1 FAT1 ARHGEF10 SYNE2 ITSN2 STAU2 UGCG OTUD4 TMEM131L TNKS PARD3 ACBD3 CNOT2 MRTFA CREB3L2	7.12e-08	856	190	23	M4500
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HDA	FNBP1 ZBTB38 MAP1B PARP8 L1CAM SLC6A15 LYST NCDN IGF1 VWA5A HPGD CELF3 UGCG ROBO1 PRKCB UNC79	9.72e-07	506	190	16	M39067
Coexpression	DAZARD_UV_RESPONSE_CLUSTER_G6	BIRC2 CHD9 REV3L ZHX2 PTK2 FAT1 OTUD4 CNOT2 CREB3L2	1.19e-06	145	190	9	M1810
Coexpression	GABRIELY_MIR21_TARGETS	FNBP1 ZBTB38 DOCK10 ZMYM2 REV3L LIFR OSBPL3 KLF5 RAB3GAP2 SYNE2 TET1 ITSN2	1.46e-06	289	190	12	M2196
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN	MAP1B ZMYM2 CHD9 MGLL REV3L ZHX2 PTK2 CRY1 FAT1 ITSN2 STAU2 UGCG PARD3 CNOT2 CREB3L2	1.73e-06	466	190	15	M13522
Coexpression	GSE19888_ADENOSINE_A3R_INH_PRETREAT_AND_ACT_BY_A3R_VS_A3R_INH_AND_TCELL_MEMBRANES_ACT_MAST_CELL_DN	MYO9B L1CAM BIRC2 LIFR G3BP2 DDX20 DNA2 NNT TOR1AIP1 CNOT2	2.16e-06	200	190	10	M7353
Coexpression	TIEN_INTESTINE_PROBIOTICS_2HR_UP	UGT1A10 UGT1A8 PTK2 EEF1A1 KLF5	2.34e-06	30	190	5	M15196
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HNBGABA	FNBP1 ZBTB38 MAP1B L1CAM ADGRB1 ADGRB3 REV3L GRM7 ST8SIA3 FRY IGF1 TENM4 TESMIN CELF3 ROBO1 PRKCB TLN2 UNC79	4.01e-06	703	190	18	M39070
Coexpression	DUTERTRE_ESTRADIOL_RESPONSE_24HR_DN	FAT4 FRAS1 PARP8 L1CAM GATA6 PPARG FCHO2 LYST NEDD9 PDLIM1 KLF5 ITSN2 EXOC6B DZIP3 CREB3L2	4.48e-06	504	190	15	M2157
Coexpression	DESCARTES_ORGANOGENESIS_WHITE_BLOOD_CELLS	FNBP1 UGT1A10 UGT1A8 PARP8 DOCK10 UGT1A9 EVI2A PPARG LCP2 MS4A7 DCLRE1C IFITM3 VWA5A HPGD IRAK4 PRKCB	1.16e-05	615	190	16	MM3641
Coexpression	GSE27786_BCELL_VS_CD4_TCELL_UP	TET2 RCC2 PLEKHG3 ZMIZ2 STAU2 DNA2 TOR1AIP1 CNOT2 EP300	1.64e-05	200	190	9	M4799
Coexpression	GSE46606_DAY1_VS_DAY3_CD40L_IL2_IL5_STIMULATED_IRF4MID_BCELL_DN	ZMYM2 CHD9 NCDN LIFR PDLIM1 ARHGEF10 ITSN2 STAU2 MRTFA	1.64e-05	200	190	9	M9842
Coexpression	GSE2128_CTRL_VS_MIMETOPE_NEGATIVE_SELECTION_DP_THYMOCYTE_NOD_UP	CHD9 IFITM2 LCP2 MS4A7 LIFR TENM4 IFITM3 HPGD IL4I1	1.64e-05	200	190	9	M6186
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HSERT	MAP1B L1CAM ADGRB1 SLC6A15 GRM7 ST8SIA3 NCDN ATL1 FRY CELF3 PRKCB MGAT4C UNC79	2.69e-05	450	190	13	M39072
Coexpression	BUSSLINGER_GASTRIC_IMMUNE_CELLS	FNBP1 ZBTB38 MYO9B PARP8 DOCK10 BIRC2 EVI2A IFITM2 SIN3A REV3L LCP2 LYST EEF1A1 NEDD9 VWA5A G3BP2 RAB3GAP2 ITSN2 IRAK4 DZIP3 OTUD4 TMEM131L PRKCB TOR1AIP1 CNOT2 EP300	3.05e-05	1492	190	26	M40023
Coexpression	GSE37605_FOXP3_FUSION_GFP_VS_IRES_GFP_TREG_NOD_DN	L1CAM DOCK10 CRY1 TESMIN PDLIM1 OSBPL3 SYNE2 ROBO1	3.69e-05	171	190	8	M8820
Coexpression	KOINUMA_TARGETS_OF_SMAD2_OR_SMAD3	RNF168 GANC UGT1A10 PARP8 CHD9 SIN3A PTPRU FCHO2 TFAP2C PTK2 FAT1 PDLIM1 GALNT11 PLEKHG3 OSBPL3 SVIL SYNE2 NUB1	4.53e-05	843	190	18	M2356
Coexpression	NUYTTEN_NIPP1_TARGETS_DN	FNBP1 NCOA6 ISYNA1 ZBTB38 CWC27 PARP8 LAMA5 OSGEP RCC2 TYMS OSBPL3 KLF5 SYNE2 TET1 CEP41 ROBO1 DHTKD1 NNT	4.67e-05	845	190	18	M18090
Coexpression	RUBENSTEIN_SKELETAL_MUSCLE_ENDOTHELIAL_CELLS	A2M VWF MGLL IFITM2 PDLIM1 IFITM3 SYNE2	6.55e-05	137	190	7	M41743
Coexpression	DAZARD_RESPONSE_TO_UV_NHEK_DN	BIRC2 CHD9 REV3L ZHX2 PTK2 FAT1 OTUD4 TMEM131L CNOT2 CREB3L2	7.21e-05	300	190	10	M8702
Coexpression	CHICAS_RB1_TARGETS_CONFLUENT	MAP1B DOCK10 GATA6 IFITM2 PPARG TYMS FRY TENM4 PDLIM1 IFITM3 OSBPL3 HPGD UGCG C7	7.24e-05	567	190	14	M2129
Coexpression	HE_LIM_SUN_FETAL_LUNG_C1_PULMONARY_NE_PRECURSOR_CELL	ESPN FNBP1 MAP1B ST8SIA3 ATL1 GAB2 KCNH6 CELF3 ROBO1 MGAT4C	8.05e-05	304	190	10	M45711
Coexpression	BAELDE_DIABETIC_NEPHROPATHY_DN	FNBP1 BIRC2 GAB2 NEDD9 FRY FAT1 HPGD UGCG OTUD4 PARD3 ACBD3 CREB3L2	8.92e-05	437	190	12	M4665
Coexpression	EIF4E_DN	FNDC3B NCOA6 PARP8 GATA6 SVIL DCTN4	9.08e-05	100	190	6	M2790
Coexpression	GSE1460_INTRATHYMIC_T_PROGENITOR_VS_DP_THYMOCYTE_DN	FNDC3B EVI2A LCP2 LYST FRY FAT1 TESMIN ZMIZ2	9.99e-05	197	190	8	M3438
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HDA2	MAP1B L1CAM SLC6A15 REV3L RNF17 ST8SIA3 FRY IGF1 VWA5A CELF3 ROBO1 PRKCB MGAT4C	1.02e-04	513	190	13	M39069
Coexpression	GSE39556_UNTREATED_VS_3H_POLYIC_INJ_MOUSE_NK_CELL_UP	LAMA5 MGLL PDLIM1 SYNE2 BUB1 DZIP3 DNA2 MRTFA	1.07e-04	199	190	8	M9410
Coexpression	BENPORATH_NANOG_TARGETS	SEMA4F ERH GANC PDHB PARP8 RNF25 GATA6 SMG5 OSGEP RFX1 ORC1 FAT1 DCLRE1C VWA5A PLEKHG3 KLF5 WDCP RAB3GAP2 DDX20	1.11e-04	988	190	19	M6616
Coexpression	GSE22025_UNTREATED_VS_TGFB1_AND_PROGESTERONE_TREATED_CD4_TCELL_UP	GATA6 LAMA5 DGKQ GAB2 IGF1 EXOC6B ROBO1 DNA2	1.11e-04	200	190	8	M8383
Coexpression	GSE41176_UNSTIM_VS_ANTI_IGM_STIM_BCELL_6H_DN	RNF168 ZMYM2 IFITM2 CPS1 IKZF5 NEDD9 PDLIM1 IFITM3	1.11e-04	200	190	8	M9923
Coexpression	GSE12392_WT_VS_IFNAR_KO_CD8A_NEG_SPLEEN_DC_UP	MYO9B BIRC2 IFITM2 PLEKHG2 LYST TMEM131L PRKCB IL4I1	1.11e-04	200	190	8	M7147
Coexpression	GSE17186_CD21LOW_VS_CD21HIGH_TRANSITIONAL_BCELL_UP	CHD9 FCHO2 LYST PTK2 GAB2 TYMS TMEM131L PRKCB	1.11e-04	200	190	8	M7168
Coexpression	GSE37301_COMMON_LYMPHOID_PROGENITOR_VS_CD4_TCELL_DN	NCOA6 ZBTB38 IFITM2 PTPRU ANKZF1 TYMS HPGD STAU2	1.11e-04	200	190	8	M8869
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HOMTN	MAP1B L1CAM ADGRB3 SLC6A15 ST8SIA3 LYST ATL1 FRY CELF3 TLN2 UNC79	1.36e-04	389	190	11	M39073
Coexpression	CAIRO_HEPATOBLASTOMA_DN	ACACB UGT1A8 MGLL IGF1 HPGD TMEM131L DHTKD1 NNT SDHB	1.53e-04	267	190	9	M13449
Coexpression	KUMAR_AUTOPHAGY_NETWORK	PLEKHG2 REV3L CPS1 TFAP2C ZNF599	1.79e-04	72	190	5	M2539
Coexpression	JONES_OVARY_ENDOTHELIAL	A2M VWF IFITM2 DYSF LIFR PDLIM1 IFITM3	1.86e-04	162	190	7	M48350
Coexpression	HE_LIM_SUN_FETAL_LUNG_C3_GRIA2_POS_ARTERIAL_ENDO_CELL	FAT4 GATA6 LAMA5 SULT1B1 PDLIM1 C7	1.96e-04	115	190	6	M45752
Coexpression	GSE7509_UNSTIM_VS_FCGRIIB_STIM_MONOCYTE_DN	TET2 VWF ACACB PARP8 CHD9 FCHO2 FRY	2.16e-04	166	190	7	M6826
Coexpression	RIGGINS_TAMOXIFEN_RESISTANCE_DN	UGT1A10 IFITM2 NEDD9 FAT1 TESMIN IFITM3 UGCG NNT	2.20e-04	221	190	8	M15835
Coexpression	LAKE_ADULT_KIDNEY_C11_THIN_ASCENDING_LIMB	MGLL FCHO2 DNAH14 PTK2 TENM4 OSBPL3 SVIL	2.42e-04	169	190	7	M39230
Coexpression	BUSSLINGER_ESOPHAGEAL_QUIESCENT_BASAL_CELLS	LAMA5 EEF1A1 PDLIM1 IFITM3 SYNE2	2.46e-04	77	190	5	M40001
Coexpression	RUBENSTEIN_SKELETAL_MUSCLE_PCV_ENDOTHELIAL_CELLS	IFITM2 LYST EEF1A1 NEDD9 LIFR PDLIM1 IFITM3 SYNE2	2.48e-04	225	190	8	M41747
Coexpression	GSE15624_3H_VS_6H_HALOFUGINONE_TREATED_CD4_TCELL_UP	MYO9B L1CAM IKZF5 NEDD9 IFITM3 PLEKHG3 SVIL	2.60e-04	171	190	7	M7105
Coexpression	GSE21360_PRIMARY_VS_QUATERNARY_MEMORY_CD8_TCELL_UP	VWF MGLL PPARG WDR91 IGF1 IFITM3 HPGD	2.99e-04	175	190	7	M7625
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_top-relative-expression-ranked_1000	SEMA4F FAT4 IRS4 MAP1B PCDHB7 REV3L GRM7 TFAP2C SCYL2 NEDD9 LIFR IGF1 TENM4 KLF5 WDCP OTUD4 ROBO1 TLN2 TNKS PYGO1	3.31e-05	806	188	20	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_1000	SEMA4F FAT4 IRS4 MAP1B DHX37 PCDHB7 MGLL REV3L TFAP2C NEDD9 TENM4 KLF5 WDCP SORCS2 OTUD4 TMEM131L ROBO1 TLN2 TNKS PYGO1	3.31e-05	806	188	20	gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_1000	FNDC3B NCOA6 INTU RNF168 ACACB GANC DHX37 DOCK10 BIRC2 PLEKHG2 REV3L ZNF599 IGF1 HPD HPGD WDCP SYNE2 TXNDC16 DNA2 ACBD3 MRTFA CREB3L2	6.38e-05	985	188	22	Facebase_RNAseq_e10.5_Lateral Nasal Eminence_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#1	TRAPPC11 NCOA6 INTU ZBTB38 RNF168 ZMYM2 BIRC2 PLEKHG2 REV3L GAB2 SCYL2 SYNE2 TET1 ITSN2 MIPEP TMEM131L TXNDC16 DCTN4 ACBD3	6.73e-05	780	188	19	Facebase_RNAseq_e10.5_Lateral Nasal Eminence_2500_K1
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	A2M FAT4 FRAS1 CPS1 DNAH1 FAT1 SLITRK2 TENM4 ROBO1 TLN2 MYO15A UNC79	2.79e-11	184	191	12	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	A2M FAT4 FRAS1 CPS1 DNAH1 FAT1 SLITRK2 TENM4 ROBO1 TLN2 MYO15A UNC79	2.79e-11	184	191	12	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	A2M FAT4 FRAS1 CPS1 DNAH1 FAT1 SLITRK2 TENM4 ROBO1 TLN2 MYO15A UNC79	2.79e-11	184	191	12	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	Severe-B_intermediate-6\|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5)	TET2 FNBP1 DOCK10 IFITM2 ACE MS4A7 FCRL3 ITSN2 UGCG PRKCB NUB1 DNAH8	6.96e-11	199	191	12	bf6ebb63ab361d9d1946225894d7be433e9befab
ToppCell	CF-Myeloid\|CF / Disease state, Lineage and Cell class	FNDC3B IFITM2 LCP2 DYSF GAB2 NEDD9 FRY IFITM3 SVIL PRKCB	1.32e-08	195	191	10	ecf604de496f389a49429d0bb211e1db6019cc8b
ToppCell	3'-Parenchyma_lung-Endothelial-Blood_vessel_EC-capillary_endothelial_cell\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	A2M VWF ACE NEDD9 LIFR FRY PDLIM1 ARHGEF10 IFITM3 HPGD	1.60e-08	199	191	10	82758d0cee9387d002e3f68a6faa324134fb7564
ToppCell	Transplant_Alveoli_and_parenchyma-Endothelial-Endothelial\|Endothelial / Tissue, Lineage and Cell class of Lung Cells from 10X	A2M VWF GATA6 ACE NEDD9 LIFR IFITM3 SYNE2 UGCG C7	1.68e-08	200	191	10	2ae62c428728c1d9d4471d4be24bd6ab074fa22c
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Activated_Alv_Cap\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	FCHO2 ACE MYCBPAP PTK2 FRY ARHGEF10 HPGD SYNE2 NUB1 IL4I1	1.68e-08	200	191	10	79e51afb57ca38aacebd0298e5e727b55c0cfff9
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D231\|Adult / Lineage, Cell type, age group and donor	FRAS1 AGR3 PTK2 KCNH6 LIFR FAT1 KLF5 SYNE2 SORCS2	5.43e-08	170	191	9	269dee5abca9f6aa079f116f0d8f1d198604d9d4
ToppCell	3'-Adult-SmallIntestine-Endothelial-blood_vessel_EC-Mature_venous_EC\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	A2M VWF IFITM2 DYSF NEDD9 LIFR FRY IFITM3 C7	6.31e-08	173	191	9	b57d14e2c2368304cb903562d06ce8228f53857c
ToppCell	COVID-19-Heart-EC_+_Pericyte\|Heart / Disease (COVID-19 only), tissue and cell type	A2M VWF MAP1B LAMA5 MGLL IFITM2 NEDD9 IFITM3 SYNE2	1.40e-07	190	191	9	a21653bfb7bafbc273f94fa7c13bfb48cf8fd562
ToppCell	cellseq-Endothelial-Endothelial_Vascular-Endothelial_capillary\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	A2M VWF IFITM2 ACE NEDD9 FRY ARHGEF10 IFITM3 HPGD	2.08e-07	199	191	9	5f67ea58512856cbdcef759088a5869720a947a8
ToppCell	medial-Endothelial\|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	A2M VWF ACE NEDD9 LIFR FRY PDLIM1 IFITM3 HPGD	2.17e-07	200	191	9	e889b593c2ae53c42944213ce8672cd886917105
ToppCell	Control_saline-Endothelial-Endothelial-Gen_Cap\|Control_saline / Treatment groups by lineage, cell group, cell type	FAT4 VWF REV3L DYSF ACE PTK2 NEDD9 LIFR HPGD	2.17e-07	200	191	9	3b97920e1e6e2f09ddba2a861baa9c00c2970f4c
ToppCell	LPS_only-Endothelial-Endothelial-Alv_Cap\|LPS_only / Treatment groups by lineage, cell group, cell type	MGLL FCHO2 DYSF ACE MYCBPAP FRY ARHGEF10 HPGD STAU2	2.17e-07	200	191	9	432384faeade8e609154fab3d96c955a8ec868dd
ToppCell	medial-2-Endothelial\|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	A2M VWF ACE NEDD9 LIFR FRY PDLIM1 IFITM3 HPGD	2.17e-07	200	191	9	70440db2d8be1e29aeb34ea5e8ac72641b5c056f
ToppCell	Parenchymal-10x3prime_v2-Endothelial-Endothelia_vascular\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	VWF LAMA5 ACE NEDD9 LIFR FRY PDLIM1 IFITM3 HPGD	2.17e-07	200	191	9	6567683f8f534310fecb44a6721909183fdc15ca
ToppCell	3'-Parenchyma_lung-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_systemic-EC_venous_systemic_L.2.2.0.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	A2M VWF IFITM2 DYSF LIFR PDLIM1 IFITM3 UGCG C7	2.17e-07	200	191	9	310c75e13be9194312a8b686804edcf13d44caf5
ToppCell	CF-Myeloid-Neutrophil\|Myeloid / Disease state, Lineage and Cell class	IFITM2 LCP2 DYSF GAB2 NEDD9 SVIL SYNE2 PRKCB	9.23e-07	175	191	8	8020c3a34f77e68e8149f87481fb1dddd2ac675e
ToppCell	facs-Lung-Endomucin\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VWF MGLL IFITM2 ACE PDLIM1 IFITM3 HPGD DNAH8	1.05e-06	178	191	8	363e523233b1800a4c8e14c7b1a7814b8da29ccd
ToppCell	CF-Myeloid-Neutrophil\|CF / Disease state, Lineage and Cell class	FNDC3B IFITM2 LCP2 DYSF GAB2 NEDD9 SVIL PRKCB	1.29e-06	183	191	8	da43827952e6fdee2ce94648c316182f272b321c
ToppCell	367C-Endothelial_cells-Endothelial-D\|367C / Donor, Lineage, Cell class and subclass (all cells)	VWF IFITM2 DYSF NEDD9 LIFR PDLIM1 IFITM3 C7	1.52e-06	187	191	8	1342bc614bc4045263c2eb0a535a1dd6c64e7abe
ToppCell	367C-Endothelial_cells-Endothelial-D-\|367C / Donor, Lineage, Cell class and subclass (all cells)	VWF IFITM2 DYSF NEDD9 LIFR PDLIM1 IFITM3 C7	1.52e-06	187	191	8	7aa206262b14b9f2aaa99e59da38b96c3594d2c9
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	FNBP1 GRM7 FRY FAT1 PLEKHG3 UGCG ROBO1 MGAT4C	1.58e-06	188	191	8	b21e93a70583c30d05c0833cd3d4d4bca44a039e
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	FRAS1 NYAP2 DOCK10 FAT1 IGF1 HPGD ROBO1 PARD3	1.58e-06	188	191	8	433a25fe52914e07e7ba695881f9bcca2d9467ff
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	FNBP1 GRM7 FRY FAT1 PLEKHG3 UGCG ROBO1 MGAT4C	1.58e-06	188	191	8	874404a4fd9aa42873f6c53dc42da22d3b0fdb9e
ToppCell	renal_medulla_nuclei-Adult_normal_reference\|renal_medulla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group	ACACB PTK2 NEDD9 LIFR FRY OSBPL3 SORCS2 EXOC6B	1.71e-06	190	191	8	f1363f7806cfc4f14fbc1b0e8dac2de813a88eee
ToppCell	Control-Endothelial-VE_Venous\|Endothelial / Disease state, Lineage and Cell class	VWF GATA6 LYST LIFR SULT1B1 UGCG ROBO1 C7	1.71e-06	190	191	8	4e30155203b4a8c5e496fcbe9348b67b98ebc625
ToppCell	10x5'-bone_marrow-Myeloid_Mac-Erythrophagocytic_macrophages\|bone_marrow / Manually curated celltypes from each tissue	A2M MGLL PPARG FCHO2 MS4A7 IGF1 IFITM3 CD276	1.71e-06	190	191	8	9db04555c98eca1df15d144fbb499e0ba06660d5
ToppCell	NS-moderate-d_16-33-Epithelial-FOXN4+\|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	INTU TRIT1 ISYNA1 TYMS TESMIN BUB1 CEP41 PYGO1	1.71e-06	190	191	8	250ca4a605c1cccd77d23383e4fe6f91cf3609ba
ToppCell	(4)_Endothelial_cells-(40)_EC-arterial\|(4)_Endothelial_cells / Cell class and subclass of bone marrow stroma cells in homeostatis	VWF L1CAM MGLL IFITM2 ACE FRY PDLIM1 TLN2	1.71e-06	190	191	8	ff774faf3f12759d11e50ed7d189288bb79e22e1
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	FRAS1 NYAP2 DOCK10 FAT1 IGF1 ROBO1 PARD3 MGAT4C	1.78e-06	191	191	8	7b386512284dfaa0e95358b28ee82632ee965e64
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive\|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group	FNDC3B ZHX2 GAB2 CRY1 KLF5 SVIL UGCG MRTFA	1.85e-06	192	191	8	8b86db2ebe0199fee0e9800566a619a24bfdeed5
ToppCell	IPF-Endothelial-VE_Venous\|Endothelial / Disease state, Lineage and Cell class	VWF ADGRB3 GATA6 LYST LIFR SULT1B1 ROBO1 C7	2.00e-06	194	191	8	e8a9005963704286bcc50785bda8d7d63ec001b1
ToppCell	RV-02._Fibroblast_II\|World / Chamber and Cluster_Paper	FNDC3B ADGRB3 CHD9 REV3L GAB2 ROBO1 C7 MRTFA	2.08e-06	195	191	8	ce90b30dcdb56d4cd925cdb79fd9d7cefd998f48
ToppCell	RA-02._Fibroblast_II\|RA / Chamber and Cluster_Paper	ADGRB3 CHD9 REV3L GAB2 ROBO1 TLN2 C7 MRTFA	2.08e-06	195	191	8	6a02ebbeb3199447ddce64d92d8809436e040eba
ToppCell	COVID-19-Heart-EC_1\|Heart / Disease (COVID-19 only), tissue and cell type	A2M VWF LAMA5 MGLL PPARG NEDD9 SYNE2 DYNLT5	2.08e-06	195	191	8	50a193475db1bb1e05b8590225a553688c372c14
ToppCell	Control-Myeloid-ncMonocyte\|Control / Disease state, Lineage and Cell class	TET2 MYO9B IFITM2 LCP2 GAB2 NEDD9 IFITM3 PRKCB	2.08e-06	195	191	8	fcb05948e7480dc53f06f3fc9b9c3fc129874edd
ToppCell	3'-Distal_airway-Endothelial\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	A2M VWF IFITM2 DYSF NEDD9 LIFR PDLIM1 IFITM3	2.24e-06	197	191	8	9ffb823c0f3f23cc85f9fd3ca24f77817e90bd86
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	A2M FAT4 VWF ADGRB3 LCP2 DYSF PDLIM1 ROBO1	2.24e-06	197	191	8	c10dd1aaec01fb662eac83dfde90e3e426665d65
ToppCell	tumor_Lung-Endothelial_cells\|tumor_Lung / Location, Cell class and cell subclass	A2M VWF DYSF ACE LIFR FRY PDLIM1 IFITM3	2.24e-06	197	191	8	6870b311c54a73723768276a58456620f5217d43
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	A2M FAT4 VWF ADGRB3 LCP2 DYSF PDLIM1 ROBO1	2.24e-06	197	191	8	2844dbcd0a673ed81c99920aa45858651a00736d
ToppCell	LAM-Endothelial-VasEndo-2\|Endothelial / Condition, Lineage and Cell class	A2M VWF GATA6 IFITM2 NEDD9 LIFR IFITM3 C7	2.33e-06	198	191	8	92bccaec01f1dbb17d5efcba30f7f800f674ca96
ToppCell	5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell-EC_arterial-EC_arterial_L.2.4.1.3\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	A2M FAT4 VWF ACE NEDD9 LIFR ARHGEF10 SYNE2	2.33e-06	198	191	8	d5990cab01de6e6f3757f5a50ef70ced711bb1fa
ToppCell	(4)_Endothelial_cells-(4)_Blood_vessel\|(4)_Endothelial_cells / Oesophagus cell shreds on cell class (v1) and cell subclass (v1)	A2M VWF LAMA5 MGLL NEDD9 LIFR FRY UGCG	2.41e-06	199	191	8	e24d70e79f25cdd3300bf5e2322713355264d4c5
ToppCell	normal_Lung-Endothelial_cells-Tip-like_ECs\|normal_Lung / Location, Cell class and cell subclass	A2M VWF DYSF ACE LIFR FRY IFITM3 HPGD	2.41e-06	199	191	8	1ae0b47fade7b1cd74c0faabcf4f12f56f62264e
ToppCell	3'-Parenchyma_lung-Endothelial-Blood_vessel_EC\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	A2M VWF IFITM2 ACE NEDD9 LIFR FRY IFITM3	2.41e-06	199	191	8	ddfb725ccbcadbd188e20b60a7567e1f8245f18d
ToppCell	3'-Adult-LymphNode-Endothelial-blood_vessel_EC-Mature_venous_EC\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	A2M VWF LAMA5 IFITM2 DYSF LIFR IFITM3 C7	2.41e-06	199	191	8	f5c8ad751d21ea0b199a02846faecd04bf100033
ToppCell	cellseq-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel-VEC\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	A2M VWF IFITM2 LYST LIFR SULT1B1 IFITM3 C7	2.41e-06	199	191	8	68412bc39639edc4045437d62548f7101b9f1989
ToppCell	3'-Parenchyma_lung-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_systemic\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	A2M VWF IFITM2 DYSF LIFR PDLIM1 IFITM3 C7	2.41e-06	199	191	8	6a7ecc3a68b9cfc49e50abaeb16e2eee3795377e
ToppCell	medial-Endothelial-Capillary\|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	A2M VWF IFITM2 DYSF NEDD9 LIFR PDLIM1 IFITM3	2.51e-06	200	191	8	fd4dcdc67db2a5dbdd54bd2ae975c66df904d4d8
ToppCell	distal-1-Endothelial-Bronchial_Vessel_2\|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	A2M VWF IFITM2 NEDD9 PDLIM1 IFITM3 SYNE2 UGCG	2.51e-06	200	191	8	aa8f8a0271c1363981e6ca1b2c1f0a8eb2652602
ToppCell	normal_Lung-Endothelial_cells-Stalk-like_ECs\|Endothelial_cells / Location, Cell class and cell subclass	VWF GATA6 IFITM2 LYST LIFR IFITM3 UGCG C7	2.51e-06	200	191	8	413ac64bbe95b8c921c5396d8b5f298fec8c4f82
ToppCell	distal-2-Endothelial\|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	A2M VWF IFITM2 NEDD9 LIFR FRY PDLIM1 IFITM3	2.51e-06	200	191	8	bc1781cff7a4602057a59ef65cf16c3a9459c628
ToppCell	medial-2-Endothelial-Capillary\|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	A2M VWF IFITM2 DYSF NEDD9 LIFR PDLIM1 IFITM3	2.51e-06	200	191	8	e4f390dfd4dd25600f0f7a17c5523283a5966e92
ToppCell	medial-Endothelial-Capillary-2\|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	A2M VWF IFITM2 DYSF NEDD9 LIFR PDLIM1 IFITM3	2.51e-06	200	191	8	4291b5453e98e20ec8150a96ccc865a5964bc645
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c04-ANXA2\|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)	ACE FRY HPGD WDCP SYNE2 UGCG IL4I1	6.25e-06	161	191	7	580153e131247e6ec12a1a920f050a0a763e7e87
ToppCell	Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Pmch_(Lateral_hypothalamus_(LH))\|Entopeduncular / BrainAtlas - Mouse McCarroll V32	A2M FRAS1 TPCN2 LCP2 MYCBPAP IGF1	7.23e-06	108	191	6	ba83418023d9d296b0edd4c4e1832a33bc9b3b69
ToppCell	Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Pmch_(Lateral_hypothalamus_(LH))-\|Entopeduncular / BrainAtlas - Mouse McCarroll V32	A2M FRAS1 TPCN2 LCP2 MYCBPAP IGF1	7.23e-06	108	191	6	673da75b24218557d01ee461a13c426040da74b9
ToppCell	Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Pmch_(Lateral_hypothalamus_(LH))--\|Entopeduncular / BrainAtlas - Mouse McCarroll V32	A2M FRAS1 TPCN2 LCP2 MYCBPAP IGF1	7.23e-06	108	191	6	a93a427ab16628c86db3bb17bfecf801f56ce270
ToppCell	PND14-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	VWF GATA6 MGLL IFITM2 ACE IFITM3 SYNE2	7.64e-06	166	191	7	7a45785a40b7425f97be67bab1c5ceb69b2bd85a
ToppCell	PND14-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_mature\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	VWF GATA6 MGLL IFITM2 ACE IFITM3 SYNE2	7.64e-06	166	191	7	bbd382812f8a84a5d99888de2d7cca3a8b5e4695
ToppCell	3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DNAH3 INTU TDRD1 GRM7 MYCBPAP DZIP3 DYNLT5	8.59e-06	169	191	7	14aadc2d1bf66eb47dac33b4d61ddb3c942caa4f
ToppCell	ICU-NoSEP-Lymphocyte-B-B_intermediate\|ICU-NoSEP / Disease, Lineage and Cell Type	DNAH3 MAP1B EEF1A1 FCRL3 PDLIM1 IGHG4 DNAH8	9.27e-06	171	191	7	c6b8578577aef4fe79c1a8ca778a068052f2c9d4
ToppCell	droplet-Lung-1m-Hematologic-myeloid-non-classical_monocyte\|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	L1CAM IFITM2 PPARG ACE IFITM3 HPGD PRKCB	9.27e-06	171	191	7	00739085fdbc4d64c9faacba2c2adeab580dd2b1
ToppCell	NS-critical-d_0-4-Epithelial-FOXN4+\|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	ISYNA1 BEND3 NCDN TYMS ZNF599 WDCP CEP41	9.63e-06	172	191	7	a00bb44d33658cb3a98accd6b60f3ce964c425b4
ToppCell	droplet-Lung-1m-Hematologic-myeloid-non-classical_monocyte-nonclassical_monocyte_l4\|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	L1CAM IFITM2 PPARG ACE IFITM3 HPGD PRKCB	9.63e-06	172	191	7	5f58ff6cac32546d07b2a49ed250b6c7aa417188
ToppCell	facs-Lung-Endomucin-24m-Endothelial\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VWF MGLL IFITM2 ACE PDLIM1 IFITM3 HPGD	1.04e-05	174	191	7	ea27868d0373843a5137569ac3f9e3f8c92c7dcc
ToppCell	facs-Lung-Endomucin-24m\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VWF IFITM2 ACE PDLIM1 IFITM3 HPGD GKN1	1.04e-05	174	191	7	60a426bfe5625999f031776ab34f7bc0d2b331be
ToppCell	facs-Lung-Endomucin-24m-Endothelial-endothelial_cell_of_lung\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VWF MGLL IFITM2 ACE PDLIM1 IFITM3 HPGD	1.08e-05	175	191	7	eedb33e3e350169d1d37f2ac9939dcf704e7b696
ToppCell	droplet-Marrow-nan-3m-Lymphocytic-NK_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	L1CAM PPARG LCP2 ACE HPGD SYNE2 PRKCB	1.08e-05	175	191	7	cf53a15bfb37b6019e7052ffdf594a9ac040900e
ToppCell	10x5'v1-week_17-19-Myeloid_neutrophil-granulo-eo/baso/mast-basophil\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	IFITM2 GAB2 NEDD9 FRY IFITM3 HPGD KLF5	1.08e-05	175	191	7	ba1befc4e5f0167452f9ceace39377d16136dfa9
ToppCell	facs-Lung-Endomucin-24m-Endothelial-Capillary_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VWF IFITM2 ACE PDLIM1 IFITM3 HPGD DNAH8	1.08e-05	175	191	7	1c7725f917f3d6b9e0a31ede9524690f408a5ea1
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c05-ZNF683\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	A2M ZBTB38 HPD PLEKHG3 OSBPL3 SYNE2 C8orf44	1.12e-05	176	191	7	5914e7635474e7cf24d446bdb1423bc0807ee9c6
ToppCell	droplet-Heart-nan-3m\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	AKAP6 ZBTB38 GATA6 CHD9 FCHO2 LYST TNKS	1.12e-05	176	191	7	749b47eac5436fa34e0d243ffbc6f1897f4e431e
ToppCell	normal_Lung-Endothelial_cells-EPCs\|normal_Lung / Location, Cell class and cell subclass	A2M VWF ACE LIFR FRY ARHGEF10 IFITM3	1.12e-05	176	191	7	71d1bd425772d89d8c550b909e0ec0e36ff22a7e
ToppCell	368C-Lymphocytic-NK_cells-NK_cell_E\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	ESPN PDHB PLEKHG2 CDPF1 VWA5A FAM219A CREB3L2	1.16e-05	177	191	7	946803293a7955116c80f403e99e4093e798ca3f
ToppCell	droplet-Limb_Muscle-MUSCLE-30m\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZBTB38 FCHO2 LYST SYNE2 ITSN2 TNKS C7	1.20e-05	178	191	7	01dafd19de04eff459253eaa9a35debf8f3deedf
ToppCell	Fetal_29-31_weeks-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	LAMA5 PLEKHG2 DYSF ACE PDLIM1 IFITM3 HPGD	1.29e-05	180	191	7	d8ef44710a77ad0fc03243428e5e1dc4d41200cb
ToppCell	facs-Skin-Anagen-3m-Epithelial-Basal_IFE\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MGLL TFAP2C EEF1A1 PDLIM1 IFITM3 KLF5 ROBO1	1.39e-05	182	191	7	22d6f4790950508e8aa27e02a8133af5f53f13c8
ToppCell	COVID-19-Heart-Fib_+_EC_+_Pericyte\|COVID-19 / Disease (COVID-19 only), tissue and cell type	VWF MAP1B ADGRB3 IGF1 TENM4 ROBO1 C7	1.39e-05	182	191	7	fbd5e332df73bf7141c822fa67b76367dc962017
ToppCell	PND10-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	FAT4 VWF MAP1B GATA6 ACE IFITM3 HPGD	1.44e-05	183	191	7	3427f3cbe6ea81709750e7dd3ff378f03ae65eab
ToppCell	E18.5-samps-Epithelial-Alveolar_epithelial-Uncommitted_AE_Progenitor\|E18.5-samps / Age Group, Lineage, Cell class and subclass	UGT1A10 GATA6 UGT1A9 MYCBPAP LMOD3 CD276	1.52e-05	123	191	6	5f002f5180fe47fe57ab888b5f0319df99ab2c59
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	A2M MAP1B ADGRB3 PLEKHG2 FRY TMEM131L ROBO1	1.55e-05	185	191	7	51dfe6ac7df8b330343b37e3bee71e5c65267189
ToppCell	COVID-19-Heart-Fib_2\|COVID-19 / Disease (COVID-19 only), tissue and cell type	MAP1B ADGRB3 IGF1 TENM4 ROBO1 C7 CREB3L2	1.55e-05	185	191	7	8f95d8e591bf7379d13f5a0545b0cb49e2b1ab5d
ToppCell	Mild-CD4+_T\|Mild / Disease group and Cell class	ESPN PPARG ACE EEF1A1 FRY SVIL IL4I1	1.55e-05	185	191	7	c28ecb63146de1b02418e5a4fad0ae7c2b66a41d
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	A2M MAP1B ADGRB3 PLEKHG2 FRY TMEM131L ROBO1	1.55e-05	185	191	7	a8c02cec3c414f3a0da9f2d6d28ce563b0030705
ToppCell	saliva-Severe-critical_progression_d28-40\|saliva / Compartment, severity and other cell annotations on 10x 3' data (130k)	TET2 NCOA6 DYSF IFITM3 SYNE2 NUB1 TOR1AIP1	1.60e-05	186	191	7	0095560ca776b01aa473ad4d6015ed78fc93ff51
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	FRAS1 NYAP2 ADGRB1 DOCK10 FAT1 IGF1 ROBO1	1.60e-05	186	191	7	310d16f4e5cffee3ea6d7635508c513a3b92131e
ToppCell	NS-moderate-d_0-4-Myeloid-Non-resident_Macrophage\|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	DOCK10 EVI2A LCP2 MS4A7 GAB2 DNAH17 IL4I1	1.66e-05	187	191	7	fcc32dbc9c5ae6176f154715a3e73aa32d78ad64
ToppCell	P15-Endothelial-large_vessel_endothelial_cell-endothelial_cell_of_artery\|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	ISYNA1 VWF MAP1B GATA6 MGLL ACE PDLIM1	1.71e-05	188	191	7	50b27fc12347ca16bd62333baf345c83cb422a8f
ToppCell	LA-13._Vascular_Smooth_Muscle\|LA / Chamber and Cluster_Paper	AKAP6 A2M FNBP1 DOCK10 NEDD9 FRY SVIL	1.71e-05	188	191	7	34e1b074a3995aa46ab194eb45115d76d1a5514d
ToppCell	Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	NYAP2 MAP1B L1CAM SLC6A15 PTPRU ANKRD34B CELF3	1.71e-05	188	191	7	b73e8a40393c3f656e2fcfe395a761b1f985c254
ToppCell	3'-Adult-Distal_Rectal-Endothelial\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	VWF LAMA5 IFITM2 NEDD9 LIFR IFITM3 ITSN2	1.77e-05	189	191	7	0c612ff5f882f2d8ec744a347780bbbe7cc471bd
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	FNDC3B MGLL PLEKHG2 NEDD9 ANKRD34B SVIL SYNE2	1.77e-05	189	191	7	8c8ca3b30d9be6c854615459a7bfba82b427c8bc
ToppCell	renal_cortex_nuclei-Adult_normal_reference\|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group	ESPN FRAS1 ACACB NEDD9 KCNH6 LIFR SYNE2	1.77e-05	189	191	7	a48df46274d51e84ffb40264646de7346104efb9
ToppCell	droplet-Heart-nan-3m-Endothelial-endocardial_endothelial_cells\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	A2M VWF GATA6 LYST DNAH1 LIFR CREB3L2	1.77e-05	189	191	7	fb2253b8463d08b3d28e952a31a23dea2c2d986b
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	FNDC3B MGLL PLEKHG2 NEDD9 ANKRD34B SVIL SYNE2	1.77e-05	189	191	7	5d902a4660a27548764bf04c6de152b565da835c
ToppCell	3'-Adult-Distal_Rectal-Endothelial-blood_vessel_EC\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	VWF LAMA5 IFITM2 NEDD9 LIFR IFITM3 ITSN2	1.77e-05	189	191	7	bc8949bd4f425ed36e2c05e653c94cb1593c5bee
ToppCell	BAL-Severe-Myeloid-TRAM-TRAM1-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	PPARG MS4A7 EEF1A1 IGF1 PDLIM1 HPGD SVIL	1.83e-05	190	191	7	0eef5a8bd88ef8a25a67d9dd522d9472fa4b3d2f
Drug	Methimazole [60-56-0]; Up 200; 35uM; MCF7; HT_HG-U133A	SEMA4F FRAS1 MYO9B ADGRB3 RNF17 NCDN LIFR FRY TESMIN HPGD ZMIZ2 CEP41	1.07e-07	196	191	12	4372_UP
Drug	fluconazole	ISYNA1 UGT1A10 UGT1A8 UGT1A9 ZHX2 KCNH6 TESMIN MRTFA	3.40e-06	107	191	8	CID000003365
Drug	naringenin chalcone	UGT1A10 UGT1A8 UGT1A9	5.74e-06	5	191	3	ctd:C027329
Drug	anthrarobin	UGT1A10 UGT1A8 UGT1A9	5.74e-06	5	191	3	ctd:C032186
Drug	Lomefloxacin hydrochloride [98079-52-8]; Down 200; 10.4uM; PC3; HT_HG-U133A	NOL10 CPS1 NEDD9 SULT1B1 PLEKHG3 SVIL BUB1 CEP41 TLN2 TOR1AIP1	6.76e-06	197	191	10	3723_DN
Drug	3-Acetamidocoumarin [779-30-6]; Up 200; 19.6uM; PC3; HT_HG-U133A	DGKQ EVI2A CPS1 TFAP2C VWA5A DNAH17 C8orf44 TLN2 NNT TOR1AIP1	7.07e-06	198	191	10	4601_UP
Drug	Carbinoxamine maleate salt [3505-38-2]; Up 200; 9.8uM; HL60; HT_HG-U133A	ZBTB38 ADGRB1 GRM7 SCYL2 KCNH6 HPD KLF5 SYNE2 CEP41 DZIP3	7.07e-06	198	191	10	2725_UP
Drug	Butacaine [149-16-6]; Up 200; 13uM; PC3; HT_HG-U133A	AKAP6 SEMA4F MYO9B DOCK10 ZMYM2 RNF17 ZMIZ2 BUB1 EXOC6B PRKCB	7.39e-06	199	191	10	5748_UP
Drug	1,1-dimethylbiguanide hydrochloride; Up 200; 0.1uM; MCF7; HG-U133A	DNAH3 ACACB MYO9B GAB2 L3MBTL1 SVIL ITSN2 TLN2 NNT RBM41	7.72e-06	200	191	10	3_UP
Drug	1,2,5,8-tetrahydroxy anthraquinone	UGT1A10 UGT1A8 UGT1A9	1.14e-05	6	191	3	ctd:C543211
Drug	alloin	UGT1A10 UGT1A8 UGT1A9	1.14e-05	6	191	3	ctd:C006457
Drug	2',5'-dihydroxychalcone	UGT1A10 UGT1A8 UGT1A9	1.14e-05	6	191	3	ctd:C107497
Drug	Fenoprofen	UGT1A10 UGT1A8 PPARG HPGD	1.34e-05	18	191	4	ctd:D005279
Drug	SureCN12722713	UGT1A10 UGT1A8 UGT1A9 HPD	1.34e-05	18	191	4	CID005488034
Drug	irinotecan HCl; Down 200; 100uM; PC3; HT_HG-U133A	FNDC3B ZMYM2 CHD9 REV3L PPARG TENM4 OSBPL3 RAB3GAP2 PARD3	1.47e-05	171	191	9	7535_DN
Drug	2',4'-dihydroxychalcone	UGT1A10 UGT1A8 UGT1A9	1.98e-05	7	191	3	ctd:C059354
Drug	phthalocyaninetetrasulfonic acid	RNF25 TYMS IGF1 HPD CD276	2.31e-05	41	191	5	CID005742784
Drug	1,4-dihydroxyanthraquinone	UGT1A10 UGT1A8 UGT1A9	3.16e-05	8	191	3	ctd:C034890
Drug	glabridin	UGT1A10 UGT1A8 UGT1A9	3.16e-05	8	191	3	ctd:C107601
Drug	Fillalbin [4540-25-4]; Down 200; 13.8uM; PC3; HT_HG-U133A	PARP8 SLC6A15 TFAP2C LIFR SULT1B1 BUB1 DZIP3 TLN2 MYO15A	4.16e-05	195	191	9	4092_DN
Drug	estradiol, USP; Up 200; 0.01uM; HL60; HG-U133A	DNAH3 L1CAM ADGRB1 DOCK10 DYSF NEDD9 ZMIZ2 DNAH17 MIPEP	4.50e-05	197	191	9	387_UP
Drug	Indoprofen [31842-01-0]; Up 200; 14.2uM; HL60; HT_HG-U133A	ACACB NOL10 L3MBTL1 HPGD KLF5 EXOC6B TLN2 TNKS SAGE1	4.50e-05	197	191	9	3007_UP
Drug	Methylhydantoin-5-(L) [40856-73-3]; Up 200; 35uM; HL60; HT_HG-U133A	MAP1B ADGRB1 GATA6 EYA3 KCNH6 L3MBTL1 ARHGEF10 HPGD DZIP3	4.50e-05	197	191	9	3040_UP
Drug	Proadifen hydrochloride [62-68-0]; Down 200; 10.2uM; PC3; HT_HG-U133A	DNAH3 ZMYM2 LAMA5 ANKZF1 SCYL2 ORC1 DCLRE1C DHTKD1 EP300	4.68e-05	198	191	9	5807_DN
Drug	Nafronyl oxalate [3200-06-4]; Down 200; 8.4uM; PC3; HT_HG-U133A	FAT4 ACACB NEDD9 L3MBTL1 ARHGEF10 ZMIZ2 RAB3GAP2 ITSN2 TLN2	4.68e-05	198	191	9	6687_DN
Drug	AC1MRQNQ	UGT1A10 UGT1A8 UGT1A9	4.70e-05	9	191	3	CID003522271
Drug	DHPASiU	UGT1A10 UGT1A8 UGT1A9	4.70e-05	9	191	3	CID000197602
Drug	3-iodophenol	UGT1A10 UGT1A8 UGT1A9	4.70e-05	9	191	3	CID000012272
Drug	AC1L4J7U	UGT1A10 UGT1A8 UGT1A9	4.70e-05	9	191	3	CID000186631
Drug	Chebi:32663	UGT1A10 UGT1A8 UGT1A9	4.70e-05	9	191	3	CID005460873
Drug	Primidone [125-33-7]; Up 200; 18.4uM; MCF7; HT_HG-U133A	ACACB CPS1 RNF17 GRM7 FRY SULT1B1 ARHGEF10 PLEKHG3 PARD3	4.87e-05	199	191	9	3402_UP
Drug	Trichlorfon [52-68-6]; Up 200; 15.6uM; PC3; HT_HG-U133A	FAT4 ZBTB38 ACACB IKZF5 NEDD9 ZMIZ2 G3BP2 UGCG NNT	4.87e-05	199	191	9	1797_UP
Drug	estradiol, USP; Down 200; 0.1uM; MCF7; HG-U133A	ACACB PARP8 CPS1 LYST TESMIN ARHGEF10 OSBPL3 HPGD CEP41	4.87e-05	199	191	9	365_DN
Drug	2-(1'H-indolo-3'-carbonyl)thiazole-4-carboxylic acid methyl ester	FAT4 TPCN2 MAP1B DOCK10 GATA6 PLEKHG2 PPARG ZHX2 GAB2 NEDD9 IGF1 RHPN2 PLEKHG3 SYNE2 STAU2 SORCS2 TLN2 DNA2 CD276	5.23e-05	807	191	19	ctd:C548651
Drug	N-phenylmaleimide	UGT1A10 UGT1A8 UGT1A9 NNT	5.29e-05	25	191	4	CID000013662
Drug	Glucuronides	UGT1A10 UGT1A8 UGT1A9	6.68e-05	10	191	3	ctd:D020719
Drug	JZL 184	MGLL PPARG ROBO1	6.68e-05	10	191	3	ctd:C534333
Drug	2,6-dihydroxyanthraquinone	UGT1A10 UGT1A8 UGT1A9	6.68e-05	10	191	3	ctd:C034889
Drug	1-hydroxypyrene	UGT1A10 UGT1A8 UGT1A9 SULT1B1 ITSN2	6.77e-05	51	191	5	ctd:C033146
Drug	isocamphane	SYNE2 SAGE1	7.00e-05	2	191	2	CID000296894
Drug	Z 338	UGT1A8 UGT1A9	7.00e-05	2	191	2	ctd:C410959
Drug	8-prenylnaringenin	VWF UGT1A10 UGT1A8 UGT1A9 IGF1	7.44e-05	52	191	5	CID000480764
Drug	sulindac sulfone	UGT1A10 UGT1A8 GATA6 PPARG HPGD	8.93e-05	54	191	5	ctd:C025463
Drug	AC1L1K7T	CLCA4 VWF UGT1A10 UGT1A8 POMC UGT1A9 PPARG TFAP2C PTK2 TYMS KCNH6 LIFR SULT1B1 IGF1 PRKCB EP300	9.09e-05	632	191	16	CID000005376
Drug	4-nitrophenyl)imidazole	UGT1A10 UGT1A8 UGT1A9	9.13e-05	11	191	3	CID000123155
Drug	AC1O5XMV	UGT1A10 UGT1A8 UGT1A9	9.13e-05	11	191	3	CID006442661
Drug	7-hydroxy-4-trifluoromethylcoumarin	UGT1A10 UGT1A8 UGT1A9 RFX1	9.67e-05	29	191	4	CID005375667
Drug	N-OH-DABZ	UGT1A10 UGT1A8 UGT1A9	1.21e-04	12	191	3	CID000051366
Drug	1-O-beta-D-glucopyranosyl-D-mannitol	UGT1A10 UGT1A8 UGT1A9	1.21e-04	12	191	3	CID000088735
Drug	4-hydroxyestrone	UGT1A10 UGT1A8 UGT1A9	1.21e-04	12	191	3	ctd:C026418
Drug	2,4,6-TCB	UGT1A10 UGT1A8 UGT1A9	1.21e-04	12	191	3	CID000037247
Drug	HCFU	TRIT1 TYMS SDHB	1.21e-04	12	191	3	CID000002577
Drug	nonanoyl-N-methylglucamide	UGT1A10 UGT1A8 UGT1A9	1.21e-04	12	191	3	CID000160090
Drug	7,7,7-triphenylheptanoic acid	UGT1A10 UGT1A8 UGT1A9	1.21e-04	12	191	3	CID000276709
Drug	luteolin	GANC UGT1A10 UGT1A8 UGT1A9 BIRC2 IGF1 SAGE1	1.22e-04	131	191	7	CID005280445
Drug	cis isomer	PDHB UGT1A10 UGT1A8 UGT1A9 SAGE1	1.26e-04	58	191	5	CID006474725
Drug	G 3012	MAP1B L1CAM LAMA5 PTK2 GAB2 ROBO1 MYO15A	1.28e-04	132	191	7	CID000120739
Drug	AC1L3G3T	UGT1A10 UGT1A8 GATA6 UGT1A9 PPARG HPGD	1.34e-04	93	191	6	CID000114866
Drug	urochloralic acid	UGT1A10 UGT1A8 UGT1A9 MGLL LYST	1.37e-04	59	191	5	CID003036914
Drug	azoxymethane	NCOA6 POMC PPARG TYMS FAT1 HPGD PRKCB SAGE1	1.39e-04	179	191	8	CID000033184
Drug	Muracein C	UGT1A10 UGT1A8 UGT1A9 ACE	1.44e-04	32	191	4	CID003086323
Drug	indole-2-carboxylic acid	UGT1A10 UGT1A8 UGT1A9 ACE	1.44e-04	32	191	4	CID000072899
Drug	UDP-alpha-d-xylopyranose	TRIT1 UGT1A10 UGT1A8 UGT1A9 MGAT4C	1.48e-04	60	191	5	CID000001165
Drug	2-hydroxyestrone	UGT1A10 UGT1A8 UGT1A9	1.56e-04	13	191	3	ctd:C024980
Drug	tritanol	UGT1A10 UGT1A8 UGT1A9	1.56e-04	13	191	3	CID000006457
Drug	5-azido-UDP-glucuronic acid	UGT1A10 UGT1A8 UGT1A9	1.56e-04	13	191	3	CID003081279
Drug	cotinine-N-glucuronide	UGT1A10 UGT1A8 UGT1A9	1.56e-04	13	191	3	CID000000411
Drug	alizarin	UGT1A10 UGT1A8 UGT1A9	1.56e-04	13	191	3	ctd:C010078
Drug	geniposide	VWF UGT1A10 UGT1A8 UGT1A9	1.62e-04	33	191	4	CID000107848
Drug	apigenin	UGT1A10 UGT1A8 POMC UGT1A9 PPARG PTK2 IGF1 SAGE1	1.68e-04	184	191	8	CID005280443
Disease	Colorectal Carcinoma	AKAP6 TET2 DNAH3 IRS4 MAP1B PARP8 PTPRU PPARG NCDN TYMS LIFR FAT1 RHPN2 KLF5 BUB1 PRKCB C2CD6 DNAH8 EP300	9.68e-08	702	184	19	C0009402
Disease	mean platelet volume	TET2 SEMA4F ZBTB38 VWF PDHB MYO9B DOCK10 CHD9 IFITM2 SIN3A FCHO2 CPS1 RCC2 EEF1A1P5 FRY PDLIM1 ZMIZ2 SVIL SYNE2 INTS4 TMEM131L NNT MRTFA	1.10e-07	1020	184	23	EFO_0004584
Disease	indole-3-carboxylate measurement	UGT1A10 UGT1A8 UGT1A9	2.39e-07	3	184	3	EFO_0800043
Disease	blood 4-oxo-retinoic acid measurement	UGT1A10 UGT1A8 UGT1A9	2.39e-07	3	184	3	EFO_0022216
Disease	urate measurement, bone density	AKAP6 FNBP1 FRAS1 UGT1A10 UGT1A8 ADGRB3 LAMA5 UGT1A9 MGLL DNAH14 ATL1 DNAH1 SCYL2 NEDD9 MIPEP ROBO1 DNAH8	3.87e-07	619	184	17	EFO_0003923, EFO_0004531
Disease	Liver Cirrhosis, Experimental	A2M ISYNA1 VWF DOCK10 POMC CPS1 LCP2 DYSF CRY1 FRY FAT1 IGF1 STAU2 UGCG PRKCB C7 DHTKD1 CD276	1.89e-06	774	184	18	C0023893
Disease	5-hydroxyindole sulfate measurement	UGT1A10 UGT1A8 UGT1A9	2.36e-06	5	184	3	EFO_0800085
Disease	N-acetyl-4-chlorophenylalanine measurement	UGT1A10 UGT1A8 UGT1A9	2.36e-06	5	184	3	EFO_0801060
Disease	nuclear receptor subfamily 1 group D member 2 measurement	UGT1A10 UGT1A8 UGT1A9	2.36e-06	5	184	3	EFO_0801853
Disease	3-carboxy-4-methyl-5-pentyl-2-furanpropionate (3-CMPFP) measurement	UGT1A10 UGT1A8 UGT1A9	4.71e-06	6	184	3	EFO_0800566
Disease	hair colour measurement	FRAS1 ZBTB38 NYAP2 TPCN2 PARP8 DOCK10 POMC SLC6A15 REV3L LYST GAB2 TENM4 SYNE2 PARD3 MGAT4C	8.04e-06	615	184	15	EFO_0007822
Disease	tissue factor measurement	UGT1A10 UGT1A8 UGT1A9 EEF1A1P5	8.06e-06	21	184	4	EFO_0010623
Disease	X-21339 measurement	UGT1A10 UGT1A8 UGT1A9	8.20e-06	7	184	3	EFO_0800808
Disease	Succinimide measurement	UGT1A10 UGT1A8 UGT1A9	1.31e-05	8	184	3	EFO_0022118
Disease	cholelithiasis, bilirubin measurement	UGT1A10 UGT1A8 UGT1A9	1.31e-05	8	184	3	EFO_0004570, EFO_0004799
Disease	X-24849 measurement	UGT1A10 UGT1A8 UGT1A9	1.31e-05	8	184	3	EFO_0800909
Disease	membrane-associated progesterone receptor component 1 measurement	UGT1A10 UGT1A8 UGT1A9	1.31e-05	8	184	3	EFO_0802740
Disease	X-16946 measurement	UGT1A10 UGT1A8 UGT1A9	1.31e-05	8	184	3	EFO_0800766
Disease	X-11793--oxidized bilirubin measurement	UGT1A10 UGT1A8 UGT1A9	1.31e-05	8	184	3	EFO_0021260
Disease	X-11530 measurement	UGT1A10 UGT1A8 UGT1A9	1.31e-05	8	184	3	EFO_0021249
Disease	sulfate of piperine metabolite C16H19NO3 (2) measurement	UGT1A10 UGT1A8 UGT1A9	1.31e-05	8	184	3	EFO_0801034
Disease	X-11522 measurement	UGT1A10 UGT1A8 UGT1A9	1.31e-05	8	184	3	EFO_0800696
Disease	X-10458 measurement	UGT1A10 UGT1A8 UGT1A9	1.31e-05	8	184	3	EFO_0800692
Disease	serum N-desmethylclozapine measurement	UGT1A10 UGT1A8 UGT1A9	1.31e-05	8	184	3	EFO_0600043
Disease	plasma clozapine measurement	UGT1A10 UGT1A8 UGT1A9	1.31e-05	8	184	3	EFO_0600038
Disease	congenital diaphragmatic hernia (biomarker_via_orthology)	GATA6 ACE IGF1 EP300	1.41e-05	24	184	4	DOID:3827 (biomarker_via_orthology)
Disease	X-11442 measurement	UGT1A10 UGT1A8 UGT1A9	1.95e-05	9	184	3	EFO_0021236
Disease	X-11441 measurement	UGT1A10 UGT1A8 UGT1A9	1.95e-05	9	184	3	EFO_0021235
Disease	circulating cell free DNA measurement	UGT1A10 UGT1A8 UGT1A9	1.95e-05	9	184	3	EFO_0004739
Disease	sulfate of piperine metabolite C18H21NO3 (3) measurement	UGT1A10 UGT1A8 UGT1A9	1.95e-05	9	184	3	EFO_0801037
Disease	sulfate of piperine metabolite C18H21NO3 (1) measurement	UGT1A10 UGT1A8 UGT1A9	1.95e-05	9	184	3	EFO_0801036
Disease	X-11880 measurement	UGT1A10 UGT1A8 UGT1A9	1.95e-05	9	184	3	EFO_0800698
Disease	protein-tyrosine kinase 6 measurement	UGT1A10 UGT1A8 UGT1A9	1.95e-05	9	184	3	EFO_0020691
Disease	testis-specific chromodomain protein Y 1 measurement	UGT1A10 UGT1A8 UGT1A9	1.95e-05	9	184	3	EFO_0802127
Disease	bilirubin measurement, response to xenobiotic stimulus	UGT1A10 UGT1A8 UGT1A9	1.95e-05	9	184	3	EFO_0004570, GO_0009410
Disease	bilirubin measurement	FAT4 MYO9B UGT1A10 UGT1A8 UGT1A9 MGLL SMG5 REV3L PPARG CPS1 MIPEP CD276	2.36e-05	442	184	12	EFO_0004570
Disease	X-21448 measurement	UGT1A10 UGT1A8 UGT1A9	2.77e-05	10	184	3	EFO_0800816
Disease	X-23974 measurement	UGT1A10 UGT1A8 UGT1A9	2.77e-05	10	184	3	EFO_0800867
Disease	bilirubin measurement, response to tenofovir	UGT1A10 UGT1A8 UGT1A9	2.77e-05	10	184	3	EFO_0004570, EFO_0009279
Disease	indoleacetate measurement	UGT1A10 UGT1A8 UGT1A9	2.77e-05	10	184	3	EFO_0021015
Disease	UDP-glucuronosyltransferase 1-6 measurement	UGT1A10 UGT1A8 UGT1A9	2.77e-05	10	184	3	EFO_0802185
Disease	xanthurenate measurement	UGT1A10 UGT1A8 UGT1A9 GRM7	3.08e-05	29	184	4	EFO_0010551
Disease	histidine betaine (hercynine) measurement	UGT1A10 UGT1A8 UGT1A9	3.79e-05	11	184	3	EFO_0800972
Disease	X-21796 measurement	UGT1A10 UGT1A8 UGT1A9	3.79e-05	11	184	3	EFO_0800825
Disease	insomnia, bilirubin measurement	UGT1A10 UGT1A8 UGT1A9	3.79e-05	11	184	3	EFO_0004570, EFO_0004698
Disease	pregnenetriol sulfate measurement	UGT1A10 UGT1A8 UGT1A9	3.79e-05	11	184	3	EFO_0800586
Disease	plasma N-desmethylclozapine measurement	UGT1A10 UGT1A8 UGT1A9	3.79e-05	11	184	3	EFO_0600039
Disease	aldosterone measurement	UGT1A10 UGT1A8 UGT1A9	3.79e-05	11	184	3	EFO_0010219
Disease	p-cresol glucuronide measurement	UGT1A10 UGT1A8 UGT1A9	5.04e-05	12	184	3	EFO_0800079
Disease	biliverdin measurement	UGT1A10 UGT1A8 UGT1A9	5.04e-05	12	184	3	EFO_0021033
Disease	body mass index, fasting blood insulin measurement	AKAP6 NYAP2 PPARG IGF1	5.20e-05	33	184	4	EFO_0004340, EFO_0004466
Disease	serum gamma-glutamyl transferase measurement	NYAP2 UGT1A10 UGT1A8 UGT1A9 CHD9 SLC6A15 PPARG CPS1 CDPF1 TENM4 RHPN2 KLF5 ZMIZ2 SVIL ROBO1 PARD3 CD276	6.37e-05	914	184	17	EFO_0004532
Disease	Colorectal Neoplasms	TET2 PPARG TYMS FAT1 RHPN2 KLF5 BUB1 PRKCB EP300	6.50e-05	277	184	9	C0009404
Disease	X-24588 measurement	UGT1A10 UGT1A8 UGT1A9	6.52e-05	13	184	3	EFO_0800898
Disease	pregnenetriol disulfate measurement	UGT1A10 UGT1A8 UGT1A9	6.52e-05	13	184	3	EFO_0800587
Disease	retinol dehydrogenase 16 measurement	UGT1A10 UGT1A8 UGT1A9	6.52e-05	13	184	3	EFO_0802007
Disease	membranous glomerulonephritis (biomarker_via_orthology)	A2M PTPRU C7	8.25e-05	14	184	3	DOID:10976 (biomarker_via_orthology)
Disease	Hereditary Diffuse Gastric Cancer	FAT4 BIRC2 PPARG ACE TFAP2C EEF1A1 TYMS PRKCB GKN1	9.97e-05	293	184	9	C1708349
Disease	Stomach Neoplasms	FAT4 BIRC2 PPARG ACE TFAP2C EEF1A1 TYMS PRKCB GKN1	1.10e-04	297	184	9	C0038356
Disease	Inappropriate ACTH Secretion Syndrome	POMC PPARG	1.16e-04	3	184	2	C0751220
Disease	hereditary spastic paraplegia 3A (implicated_via_orthology)	ATL3 ATL1	1.16e-04	3	184	2	DOID:0110791 (implicated_via_orthology)
Disease	developmental and epileptic encephalopathy 33 (implicated_via_orthology)	EEF1A1 EEF1A1P5	1.16e-04	3	184	2	DOID:0080463 (implicated_via_orthology)
Disease	Malignant neoplasm of stomach	FAT4 BIRC2 PPARG ACE TFAP2C EEF1A1 TYMS PRKCB GKN1	1.19e-04	300	184	9	C0024623
Disease	total blood protein measurement	DNAH3 ZBTB38 NYAP2 RNF168 IFITM2 PPARG CPS1 DYSF GAB2 DNAH1 TMEM131L	1.29e-04	449	184	11	EFO_0004536
Disease	Malignant neoplasm of breast	AKAP6 FNDC3B NCOA6 VWF UGT1A9 BIRC2 DYSF TYMS IGF1 FCRL3 WDCP G3BP2 SYNE2 ITSN2 ROBO1 GKN1 TOR1AIP1 EP300	1.43e-04	1074	184	18	C0006142
Disease	low density lipoprotein cholesterol measurement, body fat percentage	UGT1A10 UGT1A8 UGT1A9	1.52e-04	17	184	3	EFO_0004611, EFO_0007800
Disease	X-21441 measurement	UGT1A10 UGT1A8 UGT1A9	1.52e-04	17	184	3	EFO_0800814
Disease	angiopoietin-related protein 1 measurement	UGT1A10 UGT1A8 UGT1A9	1.82e-04	18	184	3	EFO_0801382
Disease	cholelithiasis	UGT1A10 UGT1A8 UGT1A9 FCHO2 CPS1	2.30e-04	88	184	5	EFO_0004799
Disease	COVID-19 (is_implicated_in)	A2M ACE IFITM3	2.92e-04	21	184	3	DOID:0080600 (is_implicated_in)
Disease	serum metabolite measurement	UGT1A10 UGT1A8 UGT1A9 REV3L CPS1 ACE GRM7 ATL1 HPD DNAH17 SYNE2 MIPEP EXOC6B OTUD4 TXNDC16 TLN2	3.03e-04	945	184	16	EFO_0005653
Disease	obesity (biomarker_via_orthology)	ACACB PPARG CPS1 ACE PRKCB NNT	3.31e-04	147	184	6	DOID:9970 (biomarker_via_orthology)
Disease	Seckel syndrome	ORC1 IGF1 DNA2	3.37e-04	22	184	3	C0265202
Disease	abdominal adipose tissue measurement	NYAP2 PPARG CEP41 TLN2	3.38e-04	53	184	4	EFO_0803316
Disease	HbA1c measurement	TET2 FNDC3B ZBTB38 NYAP2 ACACB MYO9B SMG5 PPARG GAB2 WDCP TET1 TMEM131L MYO15A	3.40e-04	675	184	13	EFO_0004541
Disease	Liver carcinoma	A2M PPARG ACE PTK2 TYMS ORC1 LIFR IGF1 BUB1 ROBO1 CD276	3.64e-04	507	184	11	C2239176
Disease	Pituitary-dependent Cushing's disease	POMC PPARG	3.82e-04	5	184	2	C0221406
Disease	obsolete Mendelian syndromes with cleft lip/palate	GRM7 SVIL TXNDC16	3.85e-04	23	184	3	MONDO_0015335
Disease	Acute kidney injury	A2M POMC UGT1A9 PPARG IGF1	4.36e-04	101	184	5	C2609414
Disease	Kidney Failure, Acute	A2M POMC UGT1A9 PPARG IGF1	4.36e-04	101	184	5	C0022660
Disease	Acute Kidney Insufficiency	A2M POMC UGT1A9 PPARG IGF1	4.36e-04	101	184	5	C1565662
Disease	nephrotic syndrome (implicated_via_orthology)	ACE FAT1 ITSN2	4.38e-04	24	184	3	DOID:1184 (implicated_via_orthology)
Disease	Malignant neoplasm of pancreas	PPARG TYMS KLF5 BUB1 EP300	4.56e-04	102	184	5	C0346647
Disease	urate measurement, spine bone mineral density	UGT1A10 UGT1A8 UGT1A9 ROBO1	4.77e-04	58	184	4	EFO_0004531, EFO_0007701
Disease	prostate carcinoma, type 2 diabetes mellitus	AKAP6 ZBTB38 NYAP2 TPCN2	5.10e-04	59	184	4	EFO_0001663, MONDO_0005148
Disease	Malignant neoplasm of prostate	TET2 ACE TYMS LIFR IGF1 HPGD ITSN2 IRAK4 INTS4 ROBO1 PARD3 CD276	5.19e-04	616	184	12	C0376358
Disease	Prostatic Neoplasms	TET2 ACE TYMS LIFR IGF1 HPGD ITSN2 IRAK4 INTS4 ROBO1 PARD3 CD276	5.19e-04	616	184	12	C0033578
Disease	creatinine measurement	TET2 INTU NYAP2 TPCN2 LAMA5 CHD9 SLC6A15 SIN3A CPS1 GAB2 FRY IFITM3 SVIL TMEM131L PARD3 MRTFA	5.31e-04	995	184	16	EFO_0004518
Disease	triglyceride measurement, very low density lipoprotein cholesterol measurement	NYAP2 ACACB PPARG DNAH1 CRY1 SYNE2 TNKS	5.37e-04	224	184	7	EFO_0004530, EFO_0008317
Disease	body fat percentage, fasting blood insulin measurement	NYAP2 PPARG	5.71e-04	6	184	2	EFO_0004466, EFO_0007800
Disease	insulin measurement, glucose tolerance test	NYAP2 DHX37	5.71e-04	6	184	2	EFO_0004307, EFO_0004467
Disease	hypertension (biomarker_via_orthology)	VWF PPARG CPS1 ACE PTK2 IGF1 EP300	5.81e-04	227	184	7	DOID:10763 (biomarker_via_orthology)
Disease	Alzheimer disease, gastroesophageal reflux disease	AKAP6 ADGRB3 PCDHA3 PTPRU ACE RHPN2 TXNDC16	5.96e-04	228	184	7	EFO_0003948, MONDO_0004975
Disease	free androgen index	TET2 NYAP2 UGT1A10 UGT1A8 UGT1A9 SIN3A PPARG CPS1 SULT1B1	6.00e-04	374	184	9	EFO_0007005
Disease	transient cerebral ischemia (implicated_via_orthology)	VWF SIN3A PPARG KLF5	6.94e-04	64	184	4	DOID:224 (implicated_via_orthology)
Disease	neuroblastoma, cutaneous melanoma	UGT1A10 UGT1A8 UGT1A9	6.97e-04	28	184	3	EFO_0000389, EFO_0000621
Disease	FEV/FEC ratio	AKAP6 TET2 FNDC3B FRAS1 TRIT1 GATA6 IFITM2 PPARG TFAP2C PTK2 GAB2 SVIL SYNE2 OTUD4 PARD3 MYO15A MRTFA CD276	7.08e-04	1228	184	18	EFO_0004713
Disease	hair color	TET2 FRAS1 ZBTB38 TPCN2 POMC GAB2 SYNE2 PARD3	7.84e-04	311	184	8	EFO_0003924
Disease	Hyperammonemia	CPS1 TYMS	7.96e-04	7	184	2	C0220994
Disease	Adenocarcinoma	FAT4 PPARG ACE ROBO1 GKN1	8.19e-04	116	184	5	C0001418

Protein segments in the cluster

Peptide	Gene	Start	Entry
SPNLFYALPKGMPEN	TDRD1	951	Q9BXT4
PGMPNVSNDLSQKLY	EP300	1571	Q09472
LPPAPAENEMKYDTN	ARHGEF10	31	O15013
PAAPVDPLQQAYAGM	CELF3	311	Q5SZQ8
MRKNESYLNQPAPPI	C8orf44	1	Q96CB5
IVIDKSYMNPGDQSP	TFAP2C	421	Q92754
PVTYQQTPVNMEKNP	BUB1	341	O43683
MSNIYIQEPPTNGKV	CWC27	1	Q6UX04
LKNGPESIMNSTEYP	NEDD9	566	Q14511
ENIYDMVVPFPDKPN	ACE	291	P12821
EEPKYSIHIDQMPQT	ADGRB1	1361	O14514
LHYKVNPEFNMNPPV	ADGRB3	1341	O60242
DKNLSPDGQYVPRIM	AGR3	106	Q8TD06
TVQMENTYQLGPPKH	DYNLT5	61	Q8N7M0
KYNPEAMVAPSVLSN	FCHO2	691	Q0JRZ9
NIPPYGDDMTVRKQP	FAT4	4561	Q6V0I7
HIGNPEYLMKRIPQN	CEP41	6	Q9BYV8
TADAEPPKIVQMSNY	DGKQ	731	P52824
YVGQKPPNTQSMVLL	CDPF1	26	Q6NVV7
VAAPYSKPSMTLEPN	CD276	356	Q5ZPR3
PNPEKYQESPGIQMK	DDX20	706	Q9UHI6
TYIPLNHMDPNQKGF	DHTKD1	616	Q96HY7
QQVSLPELPGEYSMK	A2M	1301	P01023
DAVPSPAQIMYNGQP	RCC2	241	Q9P258
IPMFSSYNPGEPNKV	RBM41	296	Q96IZ5
DYEESLSGKNMFPQP	OTUD4	826	Q01804
TYQSEKPSVMAPAPA	EYA3	236	Q99504
NGTLPSYQKMQEEEP	ITSN2	341	Q9NZM3
LYPDGQAQMIHPKPA	INTS4	866	Q96HW7
DDMVQSNPVLYTPGE	ISYNA1	361	Q9NPH2
PHASMNVPYIPAEKN	MSL3P1	161	P0C860
DPEMTPYLDIANQTG	NUB1	206	Q9Y5A7
MVAKFQPPPEYQLTA	BEND3	236	Q5T5X7
PQHGMLINTPYVTKD	ACACB	1686	O00763
HTTKQYLNMPPVDID	ANKRD34B	161	A5PLL1
NAAIKNSPPAMSQYI	RAB3GAP2	291	Q9H2M9
PNFYPLDMSEPQTKG	FAT1	4491	Q14517
DIPDNPPASLYTNMN	MGAT4C	336	Q9UBM8
PMPYAKILEDNSIPQ	PDHB	331	P11177
PTATPIKMPYNEAEN	TRIT1	376	Q9H3H1
VTYMAPKSRHPEEQQ	OR2A14	256	Q96R47
YPSVVDPNDPQMLAF	PARP8	581	Q8N3A8
YEIQVEATDKGNPPM	PCDHA3	316	Q9Y5H8
QEDINQGKVMYRPPP	FRAS1	1531	Q86XX4
HKIPPMEEPSYTQDN	MAP1B	1701	P46821
PNSVKPEMVAAYQGV	NCDN	676	Q9UBB6
VNSGQPPNYEMLKEE	IFITM2	11	Q01629
LQHVDSMQKDYPGLP	MGLL	101	Q99685
PPTGNFNHKSLVDYM	LMOD3	61	Q0VAK6
QPQEHMPKVLDSDGY	MYO15A	2336	Q9UKN7
PVNSGQPPNYEMLKE	IFITM3	11	Q01628
PVGPQAADIYMQTKN	ESPN	461	B1AK53
LQKPMPQGHASYILE	KCNH6	851	Q9H252
QRNPYSSPDIMHIKG	C2CD6	31	Q53TS8
IPQREKPGHMYQNED	MS4A7	21	Q9GZW8
ISEYKPLNMAGVEQP	L3MBTL1	101	Q9Y468
PEVDYKGNSTNMPET	EVI2A	66	P22794
EGESVAMNYKPSPLQ	FAM219A	36	Q8IW50
YEEHLKRMNPNSPSI	ERH	36	P84090
LDLPEIPKGSNQTMY	DNAH8	2381	Q96JB1
VYPEMQISGSHAKPQ	GALNT11	451	Q8NCW6
KQYSHLTGTQAMPPL	GANC	346	Q8TET4
DEQPLTENPRKYVMG	POMC	66	P01189
LQKAGEVVPPAMYQF	MICOS13	41	Q5XKP0
PEGAAYPQDELAMSK	LRRC14B	431	A6NHZ5
GPMPADRVTYQNHNK	L1CAM	281	P32004
HKQVLMGPYNPDTCP	ACBD3	116	Q9H3P7
KNLVPMDPNGLSDPY	PRKCB	181	P05771
VLQPPSNMHETLDGY	EXOC6B	326	Q9Y2D4
YVDDQLQQMKPHRGP	LAMA5	3216	O15230
YPNSGMLLTANETPK	NOL10	321	Q9BSC4
LENVSYMKQPAGASP	NYAP2	366	Q9P242
SNDPSPGYNIEQMAK	OSGEP	171	Q9NPF4
PPSMVVQKPDYLNDF	IKZF5	201	Q9H5V7
LSPPLMEYNINVKSH	DZIP3	611	Q86Y13
NHFIATQGPKPEMVY	PTPRU	956	Q92729
IPGPMQVKLTFENAY	INTU	251	Q9ULD6
KMVYQESPQNPSSSP	NCOA6	1111	Q14686
PPFQYIEVNGMKLTE	ORC1	561	Q13415
LYKVQVPENSPVGSM	PCDHB7	246	Q9Y5E2
LSPFAPEQPEEMYQT	GATA6	136	Q92908
LAQTDFPLQAYEPKM	DNAH1	161	Q9P2D7
DPAYKGQILTMANPI	CPS1	86	P31327
NSKLSPVHMNFPDPV	CHD9	351	Q3L8U1
QPIYEEATLNPKMAA	CHD9	1816	Q3L8U1
PKGLMYSVNPNKVDD	GKN1	116	Q9NS71
VNDLDNYMPENGEKP	GABRR1	406	P24046
YQGEELPHPKSMLQA	ATL1	336	Q8WXF7
NAYPNVIPVGTTMDK	DCLRE1C	336	Q96SD1
MGNIASGAEPYIKNP	DOCK10	516	Q96BY6
PHYKPEMQAQCTLIN	DNAH17	3536	Q9UFH2
DDLNMPAKEVYGAQP	DNAH3	2141	Q8TD57
PVNSGQPPNYEMLKE	nan	11	C9JQL5
VYLKNPQMGDPASLD	FNBP1	441	Q96RU3
DYNKAQVPGPLTPEM	ANKZF1	596	Q9H8Y5
TVPSMKGDPVNYILQ	FNDC3B	1076	Q53EP0
PEGSVPNKFYVHNDM	G3BP2	116	Q9UN86
GVNKMDSTEPPYSQK	EEF1A1	151	P68104
MAQLGPISDAKENPY	INTS14	366	Q96SY0
LMDGIQSHPQKPFYT	C7	636	P10643
LIGVNYPKPMVNHAE	CRY1	461	Q16526
INPKINNLMPGYEVA	UGCG	121	Q16739
IYQGEDLPHPKSMLQ	ATL3	331	Q6DD88
TPLIMSDYQEPLKPN	DEFB109B	71	Q30KR1
PHIGPIKSQIMFYND	DNAH14	1011	Q0VDD8
QVLQEYKEGQLTPMP	LYST	1971	Q99698
LEPMYSNVNPGDSNP	FCRL3	646	Q96P31
GVNKMDSTEPPYSQK	EEF1A1P5	151	Q5VTE0
PNIIIDYDEHKTMNP	GRM7	726	Q14831
HTDMPKTQKYQPPST	IGF1	126	P05019
PQVYTLPPSQEEMTK	IGHG4	226	P01861
TPVQNLEQSYMPPDS	IRAK4	136	Q9NWZ3
MGEAKTLTVQPAYQP	FRY	1716	Q5TBA9
PENPHTQRMNKLIEY	DCTN4	136	Q9UJW0
LKTGQMYPVPANHLD	DNA2	336	P51530
DPKMQPPTESQVTYL	DHX37	911	Q8IY37
YSPLQPDIEQGKLQM	DYSF	1771	O75923
KMALPSQHSLQEPYT	CREB3L2	406	Q70SY1
YKPQMHLPINSTVED	LIFR	1001	P42702
LRGEMNYTQEPPVQK	OSBPL3	41	Q9H4L5
ESGKYQLSPTVNMPQ	PARD3	741	Q8TEW0
QQMKKQPPSEGPSNY	PARD3	1296	Q8TEW0
PYKMNLASEPQEVLH	PDLIM1	101	O00151
RPQEKGHSPEDIYQM	IL4I1	171	Q96RQ9
GQNDNSEYVPMLPGK	IRS4	821	O14654
NYLQSDVPKPMTALV	TESMIN	246	Q9Y4I5
GLMPVAQQPVYCASK	HPGD	141	P15428
AVDNPIFYKPNTAML	NNT	1051	Q13423
EENYVPMQNPVSASP	GAB2	581	Q9UQC2
NYEESIKMPINEPAP	HPD	231	P32754
MPAENSPAPAYKVSS	PYGO1	1	Q9Y3Y4
IPSEMPSPNFGKNIY	SLC6A15	681	Q9H2J7
FPEPQPVENMKLYHS	SEMA4F	481	O95754
QPKAQSAMSPYLVPD	SMG5	846	Q9UPR3
MPFLQEDLYSAPQPA	SVIL	2031	O95425
NNGPMDVISPHSYKS	TMEM131L	916	A2VDJ0
HYKQMEGDRNVPPVP	SYNE2	6466	Q8WXH0
MATQAYTELQAAPPP	RFX1	1	P22670
YEQLMAQEHSPPKPS	PLEKHG3	991	A1L390
VHQGIYMSPENPALA	PTK2	436	Q05397
QLYNKPHEEPSNSLM	PPARG	121	P37231
VMPLQFSKELDAYNP	SORCS2	961	Q96PQ0
FYNPSEPMEIPQHKL	PIWIL4	226	Q7Z3Z4
CQNPIYMQKEGDPVA	SLITRK2	696	Q9H156
LPPGYKIEVQTNDMV	SIN3A	186	Q96ST3
SLLPDVSPIMNKHYN	ST8SIA3	146	O43173
ANLIDYPSMKNALIP	SCYL2	476	Q6P3W7
NMQPLHVSVPKGASY	WDR17	916	Q8IZU2
AAMSQAPVKENIPYS	RHPN2	326	Q8IUC4
GAPPMDSSYAKILQQ	MRTFA	251	Q969V6
EVMKDNPLVNYTHLP	SULT1B1	231	O43704
NKPVNGPKSESMDYS	TET1	661	Q8NFU7
PGPSYQNIKSIMEDS	BIRC2	11	Q13490
MDSDQQYEKPPPLHT	AKAP6	46	Q13023
NKDVNSFPSPMIVYA	CLCA4	601	Q14CN2
IQKYPANSMGNIPSE	C12orf40	421	Q86WS4
APYVGMVTKPANEQS	CNOT2	256	Q9NZN8
GYKPPAIPNMNVFEA	RNF17	1171	Q9BXT8
LQGKQLYAVSMAPAP	RNF17	1581	Q9BXT8
YMPTVNSLPELSPQK	TXNDC16	21	Q9P2K2
PGKDPMTDARNNPYT	ZNF599	186	Q96NL3
KPLPMEFEAYINASG	UGT1A10	281	Q9HAW8
EASVMYPNPDPLETQ	TRAPPC11	371	Q7Z392
PNSYNHMDPDKLNGL	TOR1AIP1	546	Q5JTV8
PNLVYMVTGNPASDE	VWF	1601	P04275
HYQTGQPLPKNMVSR	MIPEP	546	Q99797
AKPMNYIPVTPSVQQ	REV3L	2571	O60673
LGYLSPKDMNQPSSS	STAU2	436	Q9NUL3
YNVPEEKMEKGQPQP	SAGE1	251	Q9NXZ1
SLKAAPEPQQPMELY	RNF25	211	Q96BH1
ITYQIMKPEAPSQTA	TNKS	1306	O95271
FQIEGYNPHPTIKME	TYMS	296	P04818
QEPIDPLVMGKYTQS	MYCBPAP	896	Q8TBZ2
QLHNVIPGYPKPDMD	TENM4	2481	Q6N022
SAMVSFYPNIPEDQP	VWA5A	261	O00534
AAFYMQSVHLPGKPQ	PHC1	621	P78364
PPEDTQNGMVQEYKV	ROBO1	801	Q9Y6N7
KPLPMEFEAYINASG	UGT1A9	281	O60656
QMVPNRQKGSPDEYH	RNF168	461	Q8IYW5
YMSPNQEVKSPFLPD	ZMIZ2	386	Q8NF64
SPPQQMPYNVKTHIS	ZNF347	221	Q96SE7
PNMTTQKGPENLHYD	ZMYM2	806	Q9UBW7
MAESPKNGGDVVPQY	ZHX2	716	Q9Y6X8
MKTQDDGVLPPYDVN	TTTY13	1	Q9BZ97
PVDDPSMYQLKGAAK	TLN2	2106	Q9Y4G6
QSEPVKDPYVMFPQN	PLEKHG2	481	Q9H7P9
PKYQMQEEPLPQGND	ZBTB38	866	Q8NAP3
TFNIPPNSKDMTPYA	WDCP	236	Q9H6R7
PHMQTYEVDLNKCGP	SDHB	56	P21912
PPNLSNPNMDYKNGE	TET2	1741	Q6N021
ALVQHKLPPYVSNMD	WDR91	221	A4D1P6
TANNPDVMIPAYSKN	TPCN2	271	Q8NHX9
HLQPLAGTPEATYQM	TPCN2	706	Q8NHX9
KPLPMEFEAYINASG	UGT1A8	281	Q9HAW9
LYHPPSAMQQGPKEF	UNC79	2391	Q9P2D8
AEMLQNLTPPPSYAA	KLF5	316	Q13887
LPAKPFPNSNSMYID	LCP2	161	Q13094
EDNKYFLGTPVMEPA	MYO9B	616	Q13459